This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other special examinations and investigations of persons without complaint or reported diagnosis
Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
156488 |
4. Check minimum number of eventsNone |
156488 |
5. Include endpointsNone |
156488 |
6. Filter based on genotype QC (FinnGen only) |
156488 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[0-1]
Similar endpoints
↥List of similar endpoints to
Other special examinations and investigations of persons without complaint or reported diagnosis
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for examination and investigation
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 156488 | 99791 | 56697 |
| Unadjusted period prevalence (%) | 30.75 | 34.02 | 24.99 |
| Median age at first event (years) | 53.02 | 49.76 | 58.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1161
- Matched controls
- 8344
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z01.1
ICD-10 Finland
Examination of ears and hearing
915.5
323.0
463
6
Z01.8
ICD-10 Finland
Other specified special examinations
651.9
323.0
413
7
Z01.0
ICD-10 Finland
Examination of eyes and vision
1316.6
264.3
279
*
N02BE01
ATC
paracetamol; systemic, rectal
5.0
137.0
729
2103
J01DB01
ATC
cefalexin; oral
4.9
130.1
634
1634
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
14.3
126.7
243
151
A98
ICPC
Health maint/preventive medicine
6.1
113.9
386
632
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
5.7
113.0
411
734
Z97.4
ICD-10 Finland
Presence of external hearing-aid
10.5
92.7
205
167
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.7
92.7
643
2077
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.4
89.9
327
561
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
46.2
85.6
116
20
SPAT1256
SPAT
Intramuscular and subcutaneous injection
7.8
81.4
215
236
Z00.0
ICD-10 Finland
General medical examination
18.6
78.4
134
58
I10
ICD-10 Finland
Essential (primary) hypertension
3.4
78.3
593
1962
A02BC02
ATC
pantoprazole; systemic
3.5
78.1
530
1609
SPAT1263
SPAT
Sampling
5.8
77.0
255
383
SPAT1301
SPAT
No procedures
6.2
73.1
229
318
A28
ICPC
Limited function/disability NOS
5.8
72.3
240
359
SPAT1325
SPAT
Vaccination
6.0
69.1
222
317
H91.1
ICD-10 Finland
Presbycusis
6.5
68.6
205
266
L28
ICPC
Limited function/disability (L)
6.7
66.6
195
245
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
9.7
66.6
152
128
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
6.2
66.3
207
284
C07AB07
ATC
bisoprolol; oral
3.0
65.8
594
2136
SPAT1216
SPAT
Assessment of functional ability
7.6
63.1
167
180
C10AA01
ATC
simvastatin; oral
3.2
62.3
454
1392
S18
ICPC
Laceration/cut
7.0
61.4
172
202
J01CA04
ATC
amoxicillin; systemic
2.9
60.5
598
2240
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
6.8
60.5
173
209
AA1AD
NOMESCO Finland
CT of head and brain
5.0
60.4
228
390
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
7.2
59.6
164
187
G04CA02
ATC
tamsulosin; oral
2.9
59.1
539
1910
SAA01
NOMESCO Finland
Simple examination of mouth
5.7
58.4
194
285
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.2
57.8
266
555
SPAT1254
SPAT
Administration of medicine
6.2
57.2
175
231
N40
ICD-10 Finland
Hyperplasia of prostate
3.0
56.6
458
1487
SPAT1249
SPAT
Treatment-related counselling outside office
6.3
56.4
171
223
P20
ICPC
Memory disturbance
6.7
55.4
160
195
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
4.6
54.9
225
417
H25.1
ICD-10 Finland
Senile nuclear cataract
2.8
54.3
517
1851
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
7.2
54.2
148
166
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
83.7
53.1
66
6
SPAT1222
SPAT
Counselling/guidance promoting independent living
5.9
51.9
166
231
XKD00
NOMESCO Finland
Uroflowmetry
4.0
51.5
246
526
A02BC05
ATC
esomeprazole; systemic
3.5
51.4
294
732
A04
ICPC
Weakness/tiredness general
7.2
50.3
136
150
C03CA01
ATC
furosemide; systemic
2.6
50.1
739
3360
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
5.7
48.8
160
229
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.6
48.7
272
661
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.6
48.7
525
1986
DFF00
NOMESCO Finland
Pure tone audiometry
49.3
48.7
65
10
Z3229
NOMESCO Finland
Other healthcare associate professional
5.7
48.3
157
222
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.1
47.5
339
985
WX110
NOMESCO Finland
Local anesthesy
4.0
46.8
221
464
R42
ICD-10 Finland
Dizziness and giddiness
3.5
46.4
261
635
KMAK
NOMESCO Finland
NA
6.1
45.7
140
183
UJF32
NOMESCO Finland
Coloscopy
4.0
44.0
208
435
H13
ICPC
Plugged feeling ear
8.4
44.0
107
99
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
6.6
44.0
127
153
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
5.9
44.0
138
186
SFA10
NOMESCO Finland
Fillning on one surface of tooth
7.0
43.2
119
134
R5140
NOMESCO Finland
Monitoring the use of the aid
8.7
42.1
100
89
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.5
41.7
494
1920
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
41.4
279
768
Z3231
NOMESCO Finland
Registered nurse
3.5
41.1
231
557
SAA02
NOMESCO Finland
Basic examination of mouth
5.5
40.6
135
195
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
5.7
39.5
126
173
SPAT1310
SPAT
Counselling related to known health issue
7.3
39.1
104
111
SPAT1153
SPAT
Removal of sutures
7.0
38.7
106
118
K02.1
ICD-10 Finland
Caries of dentine
5.6
38.7
126
177
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
38.5
433
1619
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.1
38.4
262
725
R06.0
ICD-10 Finland
Dyspnoea
3.1
38.2
253
685
DFF15
NOMESCO Finland
Speech audiometry
87.9
38.1
47
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
6.0
37.9
117
154
M01AX05
ATC
glucosamine; oral
4.1
37.3
166
326
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.7
36.9
118
162
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
6.6
36.2
103
121
J01CE02
ATC
phenoxymethylpenicillin; oral
2.4
36.1
414
1554
M54.5
ICD-10 Finland
Low back pain
5.1
36.1
128
199
N06AX11
ATC
mirtazapine; oral
3.3
36.0
220
559
SPAT1053
SPAT
Memory test
5.0
36.0
130
206
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
4.4
35.9
146
262
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
+∞
35.9
39
*
M01AH05
ATC
etoricoxib; oral
3.7
35.3
180
398
R07.4
ICD-10 Finland
Chest pain, unspecified
3.5
35.2
190
440
J01MA02
ATC
ciprofloxacin; systemic
2.4
34.8
425
1640
R53
ICD-10 Finland
Malaise and fatigue
2.9
34.7
257
746
C08CA01
ATC
amlodipine; oral
2.7
34.6
301
965
DAX08
NOMESCO Finland
Fitting of hearing aid
19.5
34.5
57
22
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
2.6
33.9
318
1063
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
33.8
379
1394
SAA03
NOMESCO Finland
Extended examination of mouth
6.7
33.7
95
110
N03AX16
ATC
pregabalin; oral
4.9
33.7
123
197
SPAT1312
SPAT
General health counselling
6.5
33.5
96
114
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
7.3
33.1
87
91
Z01.9
ICD-10 Finland
Special examination, unspecified
42.0
32.9
45
8
Z01.2
ICD-10 Finland
Dental examination
8.0
32.7
81
77
R01AD09
ATC
mometasone; nasal
3.6
32.7
172
389
L03
ICPC
Low back symptom/complaint
11.4
32.3
66
44
UKC02
NOMESCO Finland
Cystoscopy
2.8
32.3
254
762
SPAT1100
SPAT
Long-term monitoring of blood pressure
6.8
31.9
88
99
SPAT1260
SPAT
Consultation of another employee
8.0
31.6
78
74
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.2
31.3
464
1938
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.5
31.2
123
213
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
3.5
30.9
165
376
C09AA05
ATC
ramipril; oral
2.6
30.8
282
923
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
133.3
30.3
36
*
SPAT1229
SPAT
Assessment of need for aid
7.1
30.3
81
87
M01AC06
ATC
meloxicam; systemic, rectal
2.8
30.1
234
694
SPAT1262
SPAT
Handing over of treatment supplies
5.0
29.9
106
164
R02
ICPC
Shortness of breath/dyspnoea
8.2
29.9
73
68
H81
ICPC
Excessive ear wax
5.1
29.9
105
161
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
29.4
255
805
H02
ICPC
Hearing complaint
8.9
29.3
68
58
J01AA02
ATC
doxycycline; systemic
2.0
29.1
708
3610
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
29.0
562
2607
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.6
28.8
255
814
K78
ICPC
Atrial fibrillation/flutter
6.2
28.6
84
103
N02AA05
ATC
oxycodone; systemic
3.3
28.6
164
393
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
5.5
28.4
93
131
SPAT1149
SPAT
Suture or treatment of traumatic wound
6.9
28.3
77
85
M01AE01
ATC
ibuprofen; systemic, rectal
2.1
28.2
536
2458
C10AA05
ATC
atorvastatin; oral
2.8
28.2
210
605
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
7.9
27.8
69
66
H25.8
ICD-10 Finland
Other senile cataract
2.9
27.6
200
564
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.1
27.4
468
2045
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.6
27.2
105
178
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
13.0
27.2
52
30
N05AH04
ATC
quetiapine; oral
3.8
26.9
129
268
R5599
NOMESCO Finland
Other rehabilitation service
44.4
26.7
36
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
26.7
92
138
EBA00
NOMESCO Finland
Extraction of tooth
4.4
26.5
105
183
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.0
26.4
93
143
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
26.0
125
260
Z02.4
ICD-10 Finland
Examination for driving licence
5.0
25.9
91
139
SPAT1104
SPAT
Monitoring of emergency patient
9.1
25.8
59
49
SPAT1097
SPAT
Recording of ECG
6.1
25.7
76
94
L17
ICPC
Foot/toe symptom/complaint
6.7
25.7
71
80
B01AC04
ATC
clopidogrel; oral
3.1
25.3
161
415
SPAT1211
SPAT
Application of soft bandage
8.2
25.2
61
56
SPAT1251
SPAT
Organisation of medication
5.4
25.2
82
115
SPAT1305
SPAT
Counselling and guidance related to physical exercise
8.4
25.1
60
54
G04CA01
ATC
alfuzosin; oral
3.0
25.0
167
446
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
48.7
24.9
33
5
ZXA05
NOMESCO Finland
Left side
2.6
24.9
222
706
-1
NOMESCO Finland
NA
6.4
24.9
71
84
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
4.5
24.8
96
163
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
11.8
24.6
49
31
H26.4
ICD-10 Finland
After-cataract
3.2
24.3
144
353
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
6.1
24.2
72
90
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
106.8
24.1
29
*
-50
ICPC
Medication/prescr/renewal
9.7
23.8
52
40
M79.6
ICD-10 Finland
Pain in limb
3.5
23.8
125
280
SPAT1304
SPAT
Counselling and guidance related to ageing
6.5
23.7
67
78
B01AB05
ATC
enoxaparin; parenteral
3.4
23.7
129
296
ZXA00
NOMESCO Finland
Right side
2.4
23.6
231
771
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.2
23.5
80
118
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.6
23.3
117
252
E000001
ATC
NA
2.7
23.2
177
513
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
6.2
23.1
67
81
G04CB02
ATC
dutasteride; oral
4.0
23.1
101
193
Z71.8
ICD-10 Finland
Other specified counselling
6.0
23.1
69
87
-60
ICPC
Result test/procedure
9.8
23.0
50
38
SPAT1245
SPAT
Provision of support and information to patient’s family members
6.6
22.6
63
72
M01AB05
ATC
diclofenac; systemic, rectal
2.0
22.5
407
1786
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
191.2
22.5
26
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
22.4
156
427
H29
ICPC
Ear symptom/complaint other
10.3
22.2
47
34
SPAT1252
SPAT
Overall medication plan or its review
6.3
22.2
64
77
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.8
22.0
79
124
E0000UV
ATC
NA
2.3
21.9
250
898
Z00.8
ICD-10 Finland
Other general examinations
15.2
21.9
39
19
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
15.2
21.9
39
19
-31
ICPC
Medical examin/health eval partial
7.4
21.8
56
57
WZB00
NOMESCO Finland
Telephone receipt or other advice
6.3
21.6
62
74
R05
ICPC
Cough
6.9
21.6
58
63
ZXD05
NOMESCO Finland
Urgent procedure
2.2
21.6
285
1095
R03BB04
ATC
tiotropium bromide; inhalant
2.5
21.5
190
597
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
21.4
145
389
M03BX02
ATC
tizanidine; oral
2.5
21.4
201
653
H91.9
ICD-10 Finland
Hearing loss, unspecified
9.2
21.4
48
39
A29
ICPC
General symptom/complaint other
5.6
21.3
67
90
SPAT1234
SPAT
Support of social functional capacity
6.3
21.2
61
73
C09CA01
ATC
losartan; oral
2.9
21.2
147
401
L13
ICPC
Hip symptom/complaint
7.3
21.0
54
55
N06DX01
ATC
memantine; oral
2.8
20.9
148
408
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
20.9
177
544
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
20.6
102
217
XF600
NOMESCO Finland
Bloodpressure measurement
5.5
20.6
66
91
R5120
NOMESCO Finland
Preparation of an aid
7.5
20.5
52
52
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.9
20.4
92
181
G04CA52
ATC
tamsulosin and dutasteride; systemic
4.4
20.3
79
135
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
20.3
123
306
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
20.2
22
*
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
+∞
20.2
22
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.0
20.0
324
1349
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
20.0
301
1216
Z3226
NOMESCO Finland
Physiotherapist
3.2
20.0
119
291
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
20.0
178
560
R33
ICD-10 Finland
Retention of urine
2.5
19.7
182
585
B01AF02
ATC
apixaban; oral
7.2
19.6
51
53
T90
ICPC
Diabetes non-insulin dependent
4.3
19.6
79
140
H02AB06
ATC
prednisolone; systemic
1.9
19.6
405
1845
A01
ICPC
Pain general/multiple sites
9.1
19.6
44
36
N02AJ06
ATC
codeine and paracetamol; systemic
6.0
19.3
57
71
R4110
NOMESCO Finland
Physiotherapy
3.0
19.2
124
321
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
18.9
224
815
S29
ICPC
Skin symptom/complaint other
6.0
18.7
55
68
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.6
18.7
148
436
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
2.5
18.4
160
497
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.7
18.4
67
107
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
5.9
18.3
55
70
SPAT1360
SPAT
Extensive global examination
6.4
18.3
51
59
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
18.3
156
480
AN1
HP
Coronary angiography
3.2
18.3
106
255
A11
ICPC
Chest pain NOS
14.3
18.2
33
17
215
Kela drug reimbursment
Diabetes, non-insulin-treated
5.5
18.1
57
77
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.7
18.1
143
419
-34
ICPC
Blood test
16.3
18.0
31
14
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
18.0
154
474
ZXA10
NOMESCO Finland
Bilateral
2.8
17.9
127
348
A99
ICPC
Disease/condition unspecnature/site
6.6
17.9
49
55
SPAT1167
SPAT
Insertion of urinary catheter
6.6
17.9
49
55
D11
ICPC
Diarrhoea
14.7
17.9
32
16
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
5.6
17.8
55
73
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
17.7
196
687
J01MA12
ATC
levofloxacin; systemic
2.2
17.7
202
718
D07AC01
ATC
betamethasone; topical
2.1
17.7
238
911
J01DA01
ATC
[U] cefalexin; systemic
1.7
17.6
653
3550
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.1
17.6
51
62
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
6.0
17.6
52
65
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
5.3
17.6
57
80
L57.0
ICD-10 Finland
Actinic keratosis
3.5
17.5
89
194
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
6.4
17.5
49
57
B01AA03
ATC
warfarin; systemic
1.8
17.5
423
2012
M01AH01
ATC
celecoxib; oral (coxibs)
2.6
17.3
139
413
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.2
17.2
100
241
R03AC02
ATC
salbutamol; inhalant
1.9
17.2
333
1467
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
17.1
214
793
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
17.1
144
440
R06AE07
ATC
cetirizine; oral
2.2
17.0
205
746
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
9.1
17.0
38
31
C08CA13
ATC
lercanidipine; oral
3.6
16.9
83
176
NF1AA
NOMESCO Finland
Hip X-ray examination
4.1
16.9
70
128
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.2
16.8
97
231
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
26.2
16.8
25
7
SPAT1172
SPAT
Guidance concerning hydration
9.1
16.6
37
30
R55
ICD-10 Finland
Syncope and collapse
2.5
16.5
150
475
SPAT1281
SPAT
Other administrative function
9.5
16.5
36
28
N30.0
ICD-10 Finland
Acute cystitis
3.0
16.5
106
274
A44
ICPC
General and Unspecified, Preventive immunization/medic
9.9
16.5
35
26
A02BC03
ATC
lansoprazole; oral
1.9
16.3
284
1199
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
16.3
10
484
N06AB10
ATC
escitalopram; oral
3.4
16.3
85
189
M48.0
ICD-10 Finland
Spinal stenosis
3.2
16.3
91
213
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.2
16.2
92
218
-42
ICPC
Electrical tracing
40.2
16.2
22
*
R60.0
ICD-10 Finland
Localized oedema
3.9
16.1
71
137
L82
ICD-10 Finland
Seborrhoeic keratosis
5.1
16.1
54
79
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.8
16.1
57
89
J01FA06
ATC
roxithromycin; oral
1.8
16.0
357
1641
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
4.0
16.0
68
127
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.4
16.0
83
184
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.7
16.0
76
157
HMAK
NOMESCO Finland
NA
19.1
16.0
26
10
R05
ICD-10 Finland
Cough
4.2
15.9
65
117
K59.09
ICD-10 Finland
Constipation, unspecified
5.8
15.9
48
62
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
8.0
15.9
38
35
D01BA02
ATC
terbinafine; oral; topical
2.7
15.9
119
339
XJH00
NOMESCO Finland
Transanal ultrasonography
2.8
15.8
112
307
U07
ICPC
Urine symptom/complaint other
9.6
15.8
34
26
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.8
15.6
70
138
D07AC13
ATC
mometasone; topical
2.1
15.6
207
786
L08
ICPC
Shoulder symptom/complaint
7.4
15.5
39
39
SPAT1043
SPAT
Audiometry
6.0
15.4
45
56
A97
ICPC
No disease
5.2
15.3
50
71
WX290
NOMESCO Finland
Other blockade of nerve
5.4
15.3
49
68
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
15.2
184
670
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
15.2
74
156
SPAT1131
SPAT
Colonoscopy
69.4
15.2
19
*
N17
ICPC
Vertigo/dizziness
5.9
15.2
45
57
SFA40
NOMESCO Finland
Replacement of krone of tooth
5.5
15.1
47
63
U02
ICPC
Urinary frequency/urgency
8.1
15.1
36
33
K85
ICPC
Elevated blood pressure
4.8
15.1
53
82
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
6.3
15.1
42
49
K77
ICPC
Heart failure
8.3
15.0
35
31
SPAT1081
SPAT
Cardiorespiratory global assessment
5.9
15.0
44
55
A69
ICPC
General and Unspecified, Other reason for encounter NEC
5.6
15.0
46
61
S06.0
ICD-10 Finland
Concussion
3.2
14.9
84
198
XG410
NOMESCO Finland
Flow-volume spirometry
8.6
14.9
34
29
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.2
14.8
86
206
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
14.6
16
*
L15
ICPC
Knee symptom/complaint
7.6
14.6
36
35
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
14.6
193
730
-44
ICPC
Preventive immunization/medic
5.7
14.6
44
57
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
4.3
14.5
57
99
M02AA07
ATC
piroxicam; topical
1.7
14.5
362
1718
S97
ICPC
Chronic ulcer skin
6.2
14.5
41
49
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.1
14.4
186
696
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
14.4
79
182
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
65.7
14.3
18
*
N07CA01
ATC
betahistine; oral
2.9
14.2
92
238
D82
ICPC
Teeth/gum disease
5.7
14.2
43
56
M04AA01
ATC
allopurinol; systemic
2.0
14.2
225
912
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
4.4
14.1
54
92
N03AX12
ATC
gabapentin; oral
4.1
14.1
58
106
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
3.3
14.1
77
177
R31
ICD-10 Finland
Unspecified haematuria
2.3
14.1
139
458
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
14.0
122
377
SPAT1255
SPAT
Intravenous administration of medicine
6.5
14.0
38
43
K04.5
ICD-10 Finland
Chronic apical periodontitis
4.6
13.9
51
83
S01EE01
ATC
latanoprost; ophthalmic
2.9
13.9
90
233
L29
ICPC
Musculoskeletal sympt/complt other
10.8
13.9
28
19
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.4
13.8
70
153
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
2.5
13.8
116
353
SPAT1101
SPAT
Orthostatic test
5.0
13.7
46
68
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.3
13.7
135
447
XCK00
NOMESCO Finland
Perimetry
4.3
13.6
53
92
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
13.5
52
89
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.6
13.5
49
79
L05
ICPC
Flank/axilla symptom/complaint
13.1
13.5
25
14
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
13.5
338
1597
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
4.4
13.4
51
86
R51.80
ICD-10 Finland
Headache
4.7
13.4
48
76
I50.0
ICD-10 Finland
Congestive heart failure
1.9
13.4
221
907
Z51.5
ICD-10 Finland
Palliative care
4.8
13.4
47
73
U05
ICPC
Urination problems other
8.8
13.4
30
25
J01MA14
ATC
moxifloxacin; systemic
3.2
13.2
74
174
K07
ICPC
Swollen ankles/oedema
7.4
13.2
33
33
U71
ICPC
Cystitis/urinary infection other
12.2
13.1
25
15
P70
ICPC
Dementia
5.1
13.1
43
62
-69
ICPC
Other reason for encounter NEC
8.5
13.1
30
26
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
5.3
13.1
42
59
Z02.7
ICD-10 Finland
Issue of medical certificate
5.4
13.1
41
56
J01CA08
ATC
pivmecillinam; oral
1.9
13.1
244
1046
A46
ICD-10 Finland
Erysipelas
2.3
13.0
126
412
D19
ICPC
Teeth/gum symptom/complaint
6.3
13.0
36
42
J01FA10
ATC
azithromycin; systemic
1.9
13.0
219
907
G04BD08
ATC
solifenacin; oral
4.0
12.9
54
100
R39.1
ICD-10 Finland
Other difficulties with micturition
6.8
12.9
34
37
U04
ICPC
Incontinence urine
5.9
12.7
37
46
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.2
12.7
41
58
M79.1
ICD-10 Finland
Myalgia
8.5
12.7
29
25
N05CF01
ATC
zopiclone; oral
1.6
12.6
442
2287
H61.2
ICD-10 Finland
Impacted cerumen
6.3
12.6
35
41
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
6.3
12.6
35
41
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.0
12.6
42
62
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
58.3
12.6
16
*
J02AC01
ATC
fluconazole; systemic
2.1
12.5
155
568
C09CA06
ATC
candesartan; oral
2.7
12.5
89
245
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
12.4
66
150
ZXE00
NOMESCO Finland
One hour or less
1.8
12.4
248
1090
R01AD12
ATC
fluticasone furoate; nasal
5.9
12.4
36
45
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.9
12.3
53
101
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
3.9
12.3
53
101
I25.2
ICD-10 Finland
Old myocardial infarction
1.9
12.3
199
811
A02BC01
ATC
omeprazole; systemic
1.7
12.3
308
1449
A10BH01
ATC
sitagliptin; oral
4.2
12.2
48
84
J05AB01
ATC
aciclovir; systemic
2.3
12.2
121
401
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
3.6
12.2
57
117
114
Kela drug reimbursment
Glaucoma
2.0
12.2
162
612
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
3.9
12.1
52
99
VALMI
NOMESCO Finland
NA
4.9
12.0
41
62
S01BC05
ATC
ketorolac; ophthalmic
2.6
12.0
93
269
M10.9
ICD-10 Finland
Gout, unspecified
3.2
12.0
66
153
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
11.9
80
213
G56.0
ICD-10 Finland
Carpal tunnel syndrome
4.4
11.9
45
76
R07.3
ICD-10 Finland
Other chest pain
3.3
11.9
62
139
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
+∞
11.9
13
*
Z76.0
ICD-10 Finland
Issue of repeat prescription
7.1
11.8
30
31
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
7.1
11.8
30
31
S01.0
ICD-10 Finland
Open wound of scalp
2.8
11.8
80
215
N05CF02
ATC
zolpidem; oral
2.9
11.8
76
198
K86
ICPC
Hypertension uncomplicated
5.0
11.6
39
58
XF404
NOMESCO Finland
Ambulatory ECG
4.0
11.6
49
92
M01AX17
ATC
nimesulide; oral
1.8
11.6
215
917
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
11.6
105
332
SPAT1279
SPAT
Preparation of immediate hospitalisation
8.7
11.6
26
22
N02AX02
ATC
tramadol; systemic, rectal
1.7
11.5
330
1610
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
11.5
223
966
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
7.9
11.4
27
25
L14
ICPC
Leg/thigh symptom/complaint
7.9
11.4
27
25
R06AE09
ATC
levocetirizine; oral
4.1
11.4
46
83
A03
ICPC
Fever
6.7
11.4
30
33
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
3.1
11.4
64
152
J05AB11
ATC
valaciclovir; oral
3.6
11.3
54
113
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
11.5
11.3
22
14
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
11.3
186
761
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.1
11.3
136
491
R41.0
ICD-10 Finland
Disorientation, unspecified
3.1
11.3
65
157
Z2221
NOMESCO Finland
Medical doctor
2.1
11.3
142
523
D07BC01
ATC
betamethasone and antiseptics; topical
2.4
11.3
102
321
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
11.3
212
909
A06AD11
ATC
lactulose; oral
1.6
11.2
335
1649
X58
ICD-10 Finland
Exposure to other specified factors
4.1
11.2
45
81
B03BA03
ATC
hydroxocobalamin; parenteral
2.3
11.2
107
348
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.7
11.2
51
103
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
29.1
11.2
16
*
Y77
ICPC
Malignant neoplasm prostate
6.5
11.1
30
34
M02AA10
ATC
ketoprofen; topical
2.2
11.1
120
414
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
5.9
11.1
32
40
Z01.7
ICD-10 Finland
Laboratory examination
5.4
11.0
34
46
-48
ICPC
Clarification/discussion RFE/demand
15.4
11.0
19
9
P01AB01
ATC
metronidazole; oral, rectal
1.8
11.0
213
920
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
4.0
11.0
46
86
L02AE02
ATC
leuprorelin; implant, parenteral
2.7
10.9
80
224
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
5.0
10.9
36
53
R50.9
ICD-10 Finland
Fever, unspecified
2.2
10.9
114
387
EBA05
NOMESCO Finland
Complicated extraction of tooth
5.2
10.9
35
50
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
4.3
10.8
41
70
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
3.5
10.8
53
114
A27
ICPC
Fear of other disease NOS
9.3
10.7
23
18
WX320
NOMESCO Finland
Spinalanesthesy
2.5
10.7
91
278
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.2
10.7
34
48
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
10.6
165
659
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
13.9
10.6
19
10
C01DA14
ATC
isosorbide mononitrate; oral
1.6
10.6
430
2284
K90
ICPC
Stroke/cerebrovascular accident
6.6
10.6
28
31
SDA02
NOMESCO Finland
Parodonthologic therapy
4.3
10.6
40
68
UJF30
NOMESCO Finland
Ileoscopy through colon
8.4
10.5
24
21
A05
ICPC
Feeling ill
8.4
10.5
24
21
C09DA06
ATC
candesartan and diuretics; oral
5.0
10.5
35
52
JN3AD
NOMESCO Finland
Abdominal CT examination
6.0
10.5
30
37
I49.3
ICD-10 Finland
Ventricular premature depolarization
5.1
10.5
34
49
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
10.4
71
192
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.7
10.4
46
91
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
9.5
10.4
22
17
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.3
10.3
53
118
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.0
10.3
34
50
S01ED51
ATC
timolol, combinations; ophthalmic
2.3
10.3
101
332
UDC00
NOMESCO Finland
Ear microscopy
5.2
10.3
33
47
L01
ICPC
Neck symptom/complaint
10.2
10.3
21
15
R95
ICPC
Chron obstructive pulmonary disease
8.0
10.3
24
22
N06DA02
ATC
donepezil; oral
2.2
10.3
108
368
H04
ICPC
Ear discharge
11.2
10.3
20
13
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
3.9
10.3
43
81
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
3.1
10.2
57
135
KED22
NOMESCO Finland
Transurethral resection of prostate
2.0
10.2
136
514
A08
ICPC
Swelling
8.4
10.2
23
20
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
5.9
10.1
29
36
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.9
10.1
63
161
R52.9
ICD-10 Finland
Pain, unspecified
5.4
10.1
31
42
-54
ICPC
Repair/fix-suture/cast/prosth device
8.9
10.1
22
18
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
10.1
70
192
I20.09
ICD-10 Finland
Unstable angina
2.2
10.0
108
372
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.2
10.0
39
69
M54.4
ICD-10 Finland
Lumbago with sciatica
6.0
10.0
28
34
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
15.5
10.0
17
8
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
1.8
9.9
177
744
WZA90
NOMESCO Finland
Other doctors statement
5.1
9.9
32
46
-30
ICPC
Medical examin/health eval complete
13.1
9.9
18
10
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.0
9.9
40
73
N04BC05
ATC
pramipexole; oral
3.6
9.9
46
95
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
9.9
71
198
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
3.7
9.8
44
88
I50
ICD-10 Finland
Heart failure
3.3
9.8
50
111
S76
ICPC
Skin infection other
8.5
9.8
22
19
F29
ICPC
Eye symptom/complaint other
8.5
9.8
22
19
C09AA04
ATC
perindopril; oral
2.8
9.8
64
169
R11
ICD-10 Finland
Nausea and vomiting
2.6
9.7
73
208
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
4.6
9.7
34
54
R01BA52
ATC
pseudoephedrine, combinations; oral
2.2
9.7
110
387
C05AA08
ATC
fluocortolone; rectal, topical
2.4
9.6
87
275
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
7.6
9.6
23
22
M01AB08
ATC
etodolac; oral
4.8
9.6
33
51
M03BC51
ATC
orphenadrine, combinations; systemic
2.2
9.6
108
379
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.7
9.6
28
36
H60.9
ICD-10 Finland
Otitis externa, unspecified
10.7
9.5
19
13
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
10.7
9.5
19
13
H81.0
ICD-10 Finland
Ménière disease
13.8
9.5
17
9
W19
ICD-10 Finland
Unspecified fall
2.4
9.5
86
272
H25.0
ICD-10 Finland
Senile incipient cataract
2.4
9.5
86
272
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.8
9.5
173
733
Z25.1
ICD-10 Finland
Need for immunization against influenza
8.5
9.4
21
18
M16.1
ICD-10 Finland
Other primary coxarthrosis
2.6
9.4
72
209
XCK10
NOMESCO Finland
Photography of fundus of eye
3.0
9.4
57
143
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
4.6
9.3
33
53
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
31.4
9.3
13
*
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
3.1
9.2
52
124
J01EA01
ATC
trimethoprim; systemic
1.6
9.2
294
1463
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
9.2
233
1088
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.1
9.2
36
64
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.6
9.2
68
194
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.1
9.2
115
423
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
12.4
9.2
17
10
R81
ICPC
Pneumonia
7.0
9.1
23
24
RD211
NOMESCO Finland
NA
43.5
9.1
12
*
S01EC04
ATC
brinzolamide; ophthalmic
4.7
9.1
31
48
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
4.9
9.0
30
45
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
3.2
9.0
50
117
G04BD12
ATC
mirabegron; oral
5.5
9.0
27
36
M25.5
ICD-10 Finland
Pain in joint
3.2
9.0
47
107
M01AE02
ATC
naproxen; oral, rectal
1.6
9.0
320
1635
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
9.2
8.9
19
15
R06AX27
ATC
desloratadine; oral
3.4
8.9
44
96
R13
ICD-10 Finland
Dysphagia
3.2
8.9
49
114
R03AK07
ATC
formoterol and budesonide; inhalant
2.3
8.9
85
278
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
7.7
8.9
21
20
N01
ICPC
Headache
15.6
8.9
15
7
J01FA09
ATC
clarithromycin; systemic
2.0
8.8
117
441
K59.0
ICD-10 Finland
Constipation
2.2
8.8
89
297
L12
ICPC
Hand/finger symptom/complaint
5.9
8.8
25
31
R35
ICD-10 Finland
Polyuria
3.5
8.8
42
89
ECB00
NOMESCO Finland
Suture of gingiva
12.9
8.8
16
9
S06
ICPC
Rash localized
7.0
8.8
22
23
M01AH02
ATC
rofecoxib; oral
2.0
8.7
118
448
I95.1
ICD-10 Finland
Orthostatic hypotension
3.1
8.7
49
117
B81
ICPC
Anaemia vit B12/folate deficiency
4.7
8.7
30
47
H04.10
ICD-10 Finland
Dry eye syndrome
6.5
8.7
23
26
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.8
8.7
29
44
AN4
HP
Balloon angioplasty and drug eluding stent
6.0
8.7
24
29
R05FA02
ATC
opium derivatives and expectorants; systemic
1.6
8.6
293
1475
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.2
8.6
88
296
P05
ICPC
Senility, feeling/behaving old
8.7
8.6
19
16
R21
ICPC
Throat symptom/complaint
8.7
8.6
19
16
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
5.4
8.6
26
35
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.4
8.6
26
35
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
2.6
8.5
64
184
JN4BD
NOMESCO Finland
Extensive body CT
3.6
8.5
39
80
A50
ICPC
General and Unspecified, Medication/prescr/renewal
6.7
8.5
22
24
-51
ICPC
I&d/flush/aspiration
16.9
8.5
14
6
N05AX08
ATC
risperidone; systemic
1.9
8.5
129
511
ZXC50
NOMESCO Finland
Cryotherapy
7.7
8.5
20
19
SPAT1231
SPAT
Assessment of adjustments needed in living environment
7.7
8.5
20
19
-59
ICPC
Other therap proced/minor surg NEC
13.6
8.5
15
8
R01AD08
ATC
fluticasone; nasal
2.0
8.4
113
426
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.8
8.4
147
612
H03AA01
ATC
levothyroxine sodium; systemic
2.0
8.4
113
428
SPAT1215
SPAT
Assessment of need for medical rehabilitation
8.1
8.4
19
17
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
8.1
8.4
19
17
ZX120
NOMESCO Finland
Intravenous
2.6
8.3
62
177
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.7
8.3
57
156
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
6.0
8.3
23
28
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
8.3
94
332
-35
ICPC
Urine test
18.9
8.2
13
5
S82
ICPC
Naevus/mole
6.7
8.2
21
23
S01
ICPC
Pain/tenderness of skin
14.5
8.1
14
7
S02
ICPC
Pruritus
14.5
8.1
14
7
N05BA04
ATC
oxazepam; oral
1.6
8.1
228
1094
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
7.7
8.1
19
18
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
5.0
8.1
26
38
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
12.1
8.1
15
9
-45
ICPC
Observ/health educat/advice/diet
12.1
8.1
15
9
R04.0
ICD-10 Finland
Epistaxis
2.4
8.1
70
219
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.2
8.0
83
280
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.9
8.0
116
453
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
8.2
8.0
18
16
D01
ICPC
Abdominal pain/cramps general
8.2
8.0
18
16
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.0
7.9
45
109
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
7.9
80
267
116
Kela drug reimbursment
Prostate cancer
1.9
7.9
122
486
SPAT1282
SPAT
Assessment of ability to drive and opinion
8.8
7.9
17
14
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
7.9
46
114
E86
ICD-10 Finland
Volume depletion
2.9
7.9
49
126
D12
ICPC
Constipation
7.3
7.9
19
19
S15
ICPC
Foreign body in skin
9.7
7.8
16
12
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.4
7.8
41
653
SPAT1014
SPAT
Treatment of eyes
6.6
7.8
20
22
C08CA02
ATC
felodipine; oral
1.9
7.8
121
483
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
4.0
7.7
31
57
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
10.9
7.7
15
10
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
6.1
7.7
21
25
U06
ICPC
Haematuria
7.7
7.7
18
17
S01EE04
ATC
travoprost; ophthalmic
5.4
7.7
23
31
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.5
7.7
36
76
S22.3
ICD-10 Finland
Fracture of rib
2.9
7.7
48
124
TQW99
NOMESCO Finland
Other minor procedure on skin
3.4
7.7
37
80
D16
ICPC
Rectal bleeding
26.6
7.7
11
*
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.6
7.6
55
155
M70.6
ICD-10 Finland
Trochanteric bursitis
6.9
7.6
19
20
R96
ICPC
Asthma
8.2
7.6
17
15
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.2
7.6
17
15
M09AX01
ATC
hyaluronic acid; parenteral
2.4
7.6
64
197
C07AB02
ATC
metoprolol; systemic
1.5
7.6
367
1993
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.3
7.6
20
23
H84
ICPC
Presbyacusis
5.0
7.5
24
35
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.1
7.5
42
100
B02.9
ICD-10 Finland
Zoster without complication
3.6
7.5
34
70
B82
ICPC
Anaemia other/unspecified
7.3
7.5
18
18
SPAT1212
SPAT
Extensive examination of musculoskeletal system
7.3
7.5
18
18
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
7.5
549
3233
C09DA01
ATC
losartan and diuretics; oral
2.9
7.4
46
117
D20
ICPC
Mouth/tongue/lip symptom/complaint
17.4
7.4
12
5
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
7.4
75
252
G44.2
ICD-10 Finland
Tension-type headache
4.2
7.4
28
49
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
2.3
7.4
72
236
K04.1
ICD-10 Finland
Necrosis of pulp
11.3
7.4
14
9
I44.1
ICD-10 Finland
Atrioventricular block, second degree
3.3
7.3
37
83
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
0.3
7.3
17
381
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.4
7.3
26
43
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
65.1
7.3
9
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.9
7.3
108
424
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
7.3
53
151
E000006
ATC
NA
2.7
7.3
50
138
S01GX01
ATC
cromoglicic acid; ophthalmic
3.0
7.2
42
104
R83
ICPC
Respiratory infection other
6.9
7.2
18
19
SCA03
NOMESCO Finland
Preventive oral health care, extensive
8.3
7.2
16
14
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
4.7
7.2
24
37
81
HP
Angiography of the heart and coronary arteries
1.8
7.2
122
504
M01AB55
ATC
diclofenac, combinations; oral
2.1
7.2
84
300
SPAT1139
SPAT
Nutrition survey
4.9
7.2
23
34
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
7.2
45
117
WX002
NOMESCO Finland
Sedation and analgesia
2.5
7.1
55
161
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.8
7.1
46
122
SFA00
NOMESCO Finland
Small filling
5.8
7.1
20
25
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
5.8
7.1
20
25
A06AC51
ATC
ispaghula, combinations; systemic
5.2
7.1
22
31
K88
ICPC
Postural hypotension
19.9
7.1
11
*
SPAT1240
SPAT
Therapeutic discussion
9.1
7.1
15
12
M54.2
ICD-10 Finland
Cervicalgia
9.1
7.1
15
12
U29
ICPC
Urinary symptom/complaint other
9.1
7.1
15
12
L90
ICPC
Osteoarthrosis of knee
9.1
7.1
15
12
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
7.3
7.1
17
17
R1260
NOMESCO Finland
Evaluation of communicative skills
7.3
7.1
17
17
G45.3
ICD-10 Finland
Amaurosis fugax
7.3
7.1
17
17
R01AD01
ATC
beclometasone; nasal
2.1
7.1
84
304
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.9
7.1
42
106
H66.9
ICD-10 Finland
Otitis media, unspecified
10.2
7.0
14
10
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
4.6
7.0
24
38
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.7
7.0
30
59
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
14.5
7.0
12
6
K74
ICPC
Ischaemic heart dis with angina
14.5
7.0
12
6
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
6.6
7.0
18
20
SPF30
NOMESCO Finland
Soling for prothesis
6.6
7.0
18
20
N87
ICPC
Parkinsonism
11.8
7.0
13
8
TKC22
NOMESCO Finland
Catheterisation instruction
11.8
7.0
13
8
Z2446
NOMESCO Finland
Social worker
2.8
7.0
44
115
-
ICD-10 Finland
NA
3.8
6.9
29
56
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.3
6.9
34
75
SPAT1125
SPAT
Stoma care and guidance
6.9
6.9
17
18
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.9
6.8
98
382
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.1
6.8
38
90
XA402
NOMESCO Finland
ENMG
24.1
6.8
10
*
S77
ICPC
Malignant neoplasm of skin
24.1
6.8
10
*
F51.0
ICD-10 Finland
Nonorganic insomnia
4.7
6.8
23
36
L02BB03
ATC
bicalutamide; oral
2.3
6.8
66
217
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
4.9
6.8
22
33
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.2
6.8
25
43
Z50.1
ICD-10 Finland
Other physical therapy
4.2
6.8
25
43
S21
ICPC
Skin texture symptom/complaint
3.9
6.8
27
50
XF402
NOMESCO Finland
ECG with work load test
2.9
6.8
42
107
C10AA04
ATC
fluvastatin; oral
2.1
6.7
79
284
A10BB01
ATC
glibenclamide; oral
0.6
6.7
81
996
J01FF01
ATC
clindamycin; systemic
1.7
6.7
136
594
C03DA01
ATC
spironolactone; oral
1.7
6.7
133
578
U08
ICPC
Urinary retention
7.3
6.7
16
16
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.3
6.7
16
16
D89
ICPC
Inguinal hernia
15.9
6.7
11
5
B01AF01
ATC
rivaroxaban; oral
4.5
6.7
23
37
SPAT1257
SPAT
Teaching of medicine inhalation technique
10.5
6.7
13
9
D06
ICPC
Abdominal pain localized other
10.5
6.7
13
9
I44.2
ICD-10 Finland
Atrioventricular block, complete
2.5
6.7
52
154
C10AA07
ATC
rosuvastatin; oral
3.1
6.7
37
88
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.7
6.6
22
34
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
6.5
6.6
17
19
C09CA07
ATC
telmisartan; oral
3.7
6.6
28
55
P28
ICPC
Limited function/disability (P)
32.6
6.6
9
*
M54
ICD-10 Finland
Dorsalgia
4.0
6.6
26
48
J20
ICD-10 Finland
Acute bronchitis
3.6
6.6
29
59
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
7.8
6.6
15
14
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
4.4
6.5
23
38
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.8
6.5
16
17
R03DC03
ATC
montelukast; oral
2.5
6.5
49
144
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.7
6.5
129
562
S50
ICPC
Skin, Medication/prescr/renewal
57.9
6.4
8
*
ZXD20
NOMESCO Finland
Day surgery
2.1
6.4
72
253
SPAT1146
SPAT
Puncture of abscess or incision of skin
+∞
6.4
7
*
0701
NOMESCO Finland
NA
+∞
6.4
7
*
I50.1
ICD-10 Finland
Left ventricular failure
1.7
6.4
136
602
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
5.3
6.4
19
26
A07AA02
ATC
nystatin; oral
2.4
6.4
51
154
XCD20
NOMESCO Finland
Photoangiography of eye
4.0
6.4
25
46
E000002
ATC
NA
2.1
6.4
68
236
D01AE16
ATC
amorolfine; topical
2.1
6.4
68
236
SGA01
NOMESCO Finland
Tooth opening as first aid
9.4
6.4
13
10
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.7
6.4
44
122
Y85
ICPC
Benign prostatic hypertrophy
18.1
6.3
10
*
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
6.3
101
409
H01
ICPC
Ear pain/earache
7.3
6.3
15
15
R12
ICD-10 Finland
Heartburn
7.3
6.3
15
15
B80
ICPC
Iron deficiency anaemia
10.9
6.3
12
8
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
3.0
6.3
36
89
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.6
6.3
21
33
SPAT1138
SPAT
Guidance concerning bowel function
6.5
6.2
16
18
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.6
6.2
44
124
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.9
6.2
20
30
A02BC04
ATC
rabeprazole; oral
4.2
6.2
23
40
A02BDXX
ATC
NA
3.4
6.2
29
62
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
5.1
6.2
19
27
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.5
6.2
47
138
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
6.2
32
74
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
6.2
40
107
R06
ICPC
Nose bleed/epistaxis
7.8
6.2
14
13
AN2
HP
Balloon angioplasty, including several vessels
4.0
6.2
24
44
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.3
6.1
54
170
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
3.5
6.1
28
59
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.7
6.1
40
108
ACC51
NOMESCO Finland
Release of median nerve
6.8
6.1
15
16
4289X
ICD-9 Finland
Heart failure, unspecified
0.3
6.1
10
265
C09CA03
ATC
valsartan; oral
2.6
6.1
45
129
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
3.7
6.1
26
52
XF602
NOMESCO Finland
Bloodpressure monitoring
21.7
6.0
9
*
S01EX03
ATC
NA
2.1
6.0
66
232
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
4.9
6.0
19
28
I25
ICD-10 Finland
Chronic ischaemic heart disease
2.8
6.0
38
99
A10AE04
ATC
insulin glargine; parenteral
2.5
6.0
46
136
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000494) Fungus identified in Specimen by Culture
5783
16902
1.83
314.67
1.6
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
4451
11910
1.98
314.29
10.2
5.9
mmol/l
9.8
9.6
1.34
4238
11313
(3016502) Oxygen saturation in Arterial blood
4983
13922
1.90
310.83
8.0
7.6
%
95.8
95.7
0.44
4761
13358
(3003396) Base excess in Arterial blood by calculation
5483
15840
1.85
308.99
7.7
7.1
mmol/l
1.2
0.9
8.20
4135
12545
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
5428
15647
1.85
307.89
4.5
3.9
u/l
239.8
245.4
1.51
5156
14867
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
23590
79042
1.99
307.65
6.5
5.5
umol/l
11.1
11.9
14.19
22404
74554
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20570
77947
1.58
307.65
4.5
3.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
7682
24211
1.72
307.65
1.3
1.2
u/ml
11.0
11.7
0.30
3043
9864
(3022948) Iron [Moles/volume] in Serum or Plasma
7808
22112
1.94
307.65
2.9
2.2
umol/l
13.3
13.5
1.40
7270
20427
(3035350) Ketones [Presence] in Urine by Test strip
21882
84613
1.56
307.65
4.1
3.0
estimate
0.0
0.0
0.05
4007
16872
(3002030) Lymphocytes/100 leukocytes in Blood
22510
78260
1.85
307.65
7.2
5.2
%
28.1
28.3
1.12
21194
72892
(3020682) Albumin/Creatinine [Ratio] in Urine
13998
44617
1.82
307.65
4.5
3.7
mg/mmol
10.6
8.6
3.81
9430
28179
(3024561) Albumin [Mass/volume] in Serum or Plasma
19705
65081
1.89
307.65
5.6
4.3
g/l
35.8
35.6
2.19
18374
60088
(3019309) Folate [Moles/volume] in Red Blood Cells
8684
24282
1.99
307.65
1.8
1.8
nmol/l
1157.2
1205.2
4.37
6855
18183
(3021960) Folate [Moles/volume] in Serum or Plasma
10115
32023
1.76
307.65
1.6
1.5
nmol/l
20.2
19.9
0.91
8934
27590
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
8956
27231
1.81
307.65
4.1
3.2
ng/l
519.5
590.9
0.25
6578
20506
(3013707) Erythrocyte sedimentation rate by Westergren method
33151
121097
2.21
307.65
4.7
3.3
mm/h
11.5
11.3
1.73
31122
111669
(3000963) Hemoglobin [Mass/volume] in Blood
45742
212250
2.50
307.65
24.9
15.4
g/l
135.8
137.0
57.22
45262
208830
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
5507
15683
1.88
307.65
7.6
7.2
kpa
5.1
5.1
0.89
5204
14915
(3023103) Potassium [Moles/volume] in Serum or Plasma
42899
182911
2.57
307.65
18.9
12.3
mmol/l
4.0
4.0
15.92
41979
176805
(3007164) IgA [Mass/volume] in Serum or Plasma
9770
29748
1.83
307.65
1.5
1.4
g/l
2.4
2.4
0.29
6344
18839
(3026361) Erythrocytes [#/volume] in Blood
45734
212150
2.50
307.65
24.7
15.4
e12/l
4.5
4.6
57.59
44911
204328
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5871
15476
2.05
307.65
7.9
5.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
23612
78456
2.02
307.65
6.8
5.1
e9/l
0.6
0.6
0.89
21281
65958
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
18070
57705
1.93
307.65
2.1
1.7
pmol/l
96.7
95.0
4.41
10181
29935
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
3669
8872
2.18
307.65
4.7
3.5
ng/l
96.2
88.1
3.83
3226
7612
(3026493) Urate [Moles/volume] in Serum or Plasma
11930
41996
1.58
307.65
3.0
2.3
umol/l
3729.9
5322.0
3.95
10556
36722
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
37851
159997
1.89
307.65
6.4
4.6
mmol/mol
40.5
38.8
165.37
35607
148372
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
40002
178545
1.75
307.65
4.6
3.7
mmol/l
1.4
1.4
31.57
37503
165874
(3048689) Calprotectin [Mass/mass] in Stool
6518
18102
1.95
307.65
2.5
2.5
ug/g
132.2
138.9
0.65
5172
14422
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
8142
25957
1.71
307.65
1.3
1.2
iu/ml
30.9
38.0
1.21
2494
8326
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
33651
131578
1.95
307.65
4.3
3.5
pmol/l
14.8
14.7
10.51
31115
119090
(3009508) Creatinine [Moles/volume] in Urine
14623
46299
1.86
307.65
3.6
2.9
mmol/l
7.9
8.1
6.03
12721
39059
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
42566
181931
2.46
307.65
17.0
10.6
mg/l
21.8
24.8
56.70
34905
138363
(3010813) Leukocytes [#/volume] in Blood
45753
212197
2.51
307.65
24.8
15.4
e9/l
6.8
6.7
11.27
44915
204359
(3007853) Bacteria identified in Skin by Aerobe culture
6288
16800
2.03
307.65
1.9
1.6
—
—
—
0
0
(3013512) EKG study
12568
41093
1.74
307.65
4.1
3.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
43424
194278
2.21
307.65
15.9
10.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
26439
92715
1.97
307.65
5.5
4.1
mmol/l
6.8
6.6
21.69
24677
85089
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
15451
45642
2.04
307.65
2.9
2.3
u/l
57.4
59.6
2.42
14395
41915
(3019069) Monocytes/100 leukocytes in Blood
22036
74968
1.89
307.65
7.5
5.4
%
8.6
8.6
0.44
20843
70116
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5016
12064
2.23
307.65
2.2
2.2
nmol/l
368.3
381.2
3.62
4638
11237
(3019198) Lymphocytes [#/volume] in Blood
24212
81885
1.99
307.65
6.9
5.1
e9/l
1.9
1.9
1.18
21989
70762
(3023368) Bacteria identified in Blood by Culture
12353
40169
1.75
307.65
4.6
4.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6641
18970
1.89
307.65
3.0
2.2
%
22.8
23.4
2.36
5495
16215
(3035941) MCH [Entitic mass]
45729
212093
2.50
307.65
24.6
15.3
pg
30.3
30.2
2.70
45252
208613
(3001122) Ferritin [Mass/volume] in Serum or Plasma
20504
72860
1.73
307.65
3.2
2.5
ug/l
123.8
121.5
0.41
19204
67703
(3012095) Magnesium [Moles/volume] in Serum or Plasma
7522
23318
1.75
307.65
4.1
3.1
mmol/l
0.8
0.8
0.25
7028
21744
(3037467) Urinalysis macro (dipstick) panel - Urine
30416
115841
1.88
307.65
4.9
3.5
—
—
—
0
0
(3015736) pH of Urine
17165
65452
1.51
307.65
3.8
2.8
ph
5.8
5.8
0.03
12
63
(3037522) Nuclear Ab [Titer] in Serum
7035
19940
1.92
307.65
1.4
1.3
titre
517.2
533.2
0.26
1476
3590
(3026008) Bacteria identified in Urine by Culture
13085
44418
1.67
307.65
3.3
2.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
17404
55658
1.91
307.65
3.9
3.0
ng/l
89.6
61.0
0.47
11458
34809
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
11292
34333
1.86
307.65
1.4
1.2
u/ml
1.6
1.8
0.47
3167
9876
(3042936) Bacteria identified in Isolate by Culture
6947
20556
1.83
307.65
2.3
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
13251
42150
1.81
307.65
3.7
3.0
mg/l
537.5
328.1
4.21
8785
26667
(40761535) Cells panel - Urine sediment
4181
9799
2.27
307.65
4.0
2.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
10812
34624
1.75
307.65
4.3
3.2
kg/l
1.0
1.0
0.35
1692
5122
(3018677) aPTT in Platelet poor plasma by Coagulation assay
7240
22219
1.76
307.65
2.4
1.9
s
29.7
29.9
2.08
7012
21596
(3006504) Eosinophils/100 leukocytes in Blood
21938
74462
1.89
307.65
7.1
5.2
%
2.9
2.8
5.65
20668
69214
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
33811
124991
2.21
307.65
8.4
6.4
u/l
77.2
77.9
1.77
32173
116809
(40768797) Stomach Pathology biopsy report
6543
17616
2.02
307.65
1.2
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
22233
76730
1.86
307.65
6.9
5.1
%
57.1
57.1
0.47
20982
71789
(3005322) IgE [Units/volume] in Serum or Plasma
3881
8580
2.40
307.65
1.4
1.2
u/ml
260.1
256.0
0.06
3605
7928
(3032080) INR in Blood by Coagulation assay
17990
61475
1.76
307.65
9.5
8.2
inr
1.2
1.2
0.51
5142
19834
(3009343) pH of Capillary blood
3444
7521
2.42
307.65
4.2
3.1
ph
7.4
7.4
2.95
362
1543
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
3329
7323
2.40
307.65
4.1
3.0
mmol/l
1.5
1.9
7.38
2389
5297
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
38889
171278
1.74
307.65
4.2
3.4
mmol/l
1.3
1.3
13.33
36271
158364
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
38223
168170
1.70
307.65
14.4
10.5
ml/min/173m2
83.8
84.5
6.45
32081
134160
(3024731) MCV [Entitic volume]
45730
212115
2.50
307.65
24.7
15.3
fl
90.7
90.5
13.89
45253
208630
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
3827
9311
2.17
307.65
1.8
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
6344
14553
2.39
307.65
24.2
24.5
inr
1.4
1.4
0.25
1006
1784
(3005719) IgG [Mass/volume] in Serum or Plasma
4240
10156
2.22
307.65
2.8
2.5
g/l
10.4
10.8
4.62
3913
9198
(3006315) Basophils [#/volume] in Blood
23749
78739
2.03
307.65
6.9
5.1
e9/l
0.0
0.0
2.49
21401
66195
(3019550) Sodium [Moles/volume] in Serum or Plasma
42830
182158
2.58
307.65
18.8
12.2
mmol/l
139.6
139.7
14.29
41974
176462
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
19867
65912
1.89
307.65
6.9
5.3
mmol/l
1.2
1.2
0.56
18135
59674
(3019225) pH of Specimen
4643
10793
2.30
307.65
4.7
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
14337
50882
1.60
307.65
3.2
3.4
mmol/l
2.3
2.4
10.06
12594
45246
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
43980
197053
2.34
307.65
11.9
8.1
u/l
27.1
27.0
0.20
42754
189674
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
10607
32850
1.81
307.65
2.0
1.6
mg/l
1.1
1.2
1.50
7946
25102
(3027801) Oxygen [Partial pressure] in Arterial blood
5506
15672
1.88
307.65
7.6
7.2
kpa
12.3
12.7
4.55
5199
14899
(3021601) Nitrite [Presence] in Urine by Test strip
21757
85049
1.53
307.65
5.4
4.1
estimate
0.0
0.0
0.96
4184
17227
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5364
15054
1.90
307.65
4.4
3.8
%
31.9
31.7
0.44
4049
10326
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
22428
71733
2.08
307.65
8.0
5.5
mmol/l
1.2
1.2
2.13
19340
57737
(3044889) 12 lead EKG panel
28953
119599
1.56
307.65
4.0
3.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
12144
35707
1.96
307.65
2.4
2.0
mg/l
2.9
2.9
0.27
10668
30243
(3004789) Transferrin [Mass/volume] in Serum or Plasma
7177
20390
1.92
307.65
2.9
2.2
g/l
2.4
2.3
5.22
6703
18678
(3020564) Creatinine [Moles/volume] in Serum or Plasma
44054
195617
2.47
307.65
18.9
12.3
umol/l
79.0
76.2
45.70
44037
195496
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
29258
122149
1.53
307.65
3.6
2.6
u/l
49.4
45.1
10.67
27577
114850
(3013650) Neutrophils [#/volume] in Blood by Automated count
26353
92887
1.95
307.65
9.9
8.0
e9/l
4.1
4.2
5.71
23870
78961
(3009261) Glucose [Presence] in Urine by Test strip
21989
85942
1.54
307.65
4.1
3.0
estimate
0.0
0.0
0.75
4028
16712
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
12611
36876
1.99
307.65
3.3
2.7
ng/l
1408.1
1438.3
0.30
10753
31188
(3022096) Basophils/100 leukocytes in Blood
21263
72145
1.87
307.65
7.1
5.3
%
0.7
0.7
1.65
20048
67166
(3013115) Eosinophils [#/volume] in Blood
24506
81449
2.05
307.65
7.1
5.2
e9/l
0.2
0.2
2.09
22242
70130
(42870588) Differential panel, method unspecified - Blood
16232
52662
1.84
307.65
6.8
5.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
28879
108606
1.85
307.65
5.0
3.6
e6/l
1274.0
1221.8
0.06
354
2183
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
39074
161297
2.14
307.65
5.1
4.0
mu/l
2.1
2.2
0.24
36499
147775
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
3502
7593
2.44
307.65
4.2
3.1
kpa
5.1
5.1
0.36
3232
7099
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15448
53589
1.67
307.65
3.7
2.7
u/l
32.8
34.0
0.81
14697
50607
(3022313) Gas panel - Capillary blood
2492
4998
2.61
307.65
4.4
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
11207
38232
1.63
307.65
7.4
6.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
19004
61590
1.92
307.65
2.5
2.0
nmol/l
76.0
75.5
1.41
17473
55726
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7812
21886
1.96
307.65
2.0
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
6433
17717
1.96
307.65
7.7
4.8
mmol/l
1.1
1.0
6.92
6034
16473
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
14478
41557
2.09
307.65
2.3
1.9
u/l
212.4
229.4
0.78
13646
38765
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
39468
171859
1.86
307.65
4.7
3.8
mmol/l
6.0
5.8
110.75
36665
157311
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
40309
179906
1.78
307.65
4.6
3.8
mmol/l
4.6
4.7
150.97
37933
168024
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
40801
183132
1.79
307.65
5.1
4.1
mmol/l
2.7
2.8
133.06
38222
169677
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
4373
9806
2.38
307.65
2.5
2.0
ug/l
6.9
8.5
3.57
3837
8589
(3007461) Platelets [#/volume] in Blood
45707
211828
2.50
307.65
24.8
15.4
e9/l
251.2
251.9
1.34
44975
204731
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
2161
4256
2.64
306.37
4.5
3.3
mmol/l
24.6
24.8
3.43
1994
3949
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
4092
10789
2.00
300.19
3.3
2.6
ng/l
199.1
208.4
0.56
3679
9751
(3008152) Bicarbonate [Moles/volume] in Arterial blood
3403
8429
2.12
293.47
7.4
6.5
mmol/l
24.5
24.5
0.36
3168
7764
(3028026) IgM [Mass/volume] in Serum or Plasma
3265
7991
2.14
289.91
1.9
1.9
g/l
1.3
1.3
0.45
3008
7308
(3018095) Leukocytes [#/volume] in Urine
15166
57584
1.48
288.99
4.2
3.1
e6/l
77.3
102.3
3.19
11279
38191
(3023520) Reticulocytes [#/volume] in Blood
4021
10688
1.99
287.97
2.8
2.5
e9/l
70.2
68.6
1.40
3200
7583
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
17297
67557
1.46
284.70
4.3
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5296
15542
1.81
282.31
1.9
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
3457
8745
2.08
282.23
5.4
4.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
16884
65720
1.46
282.09
2.1
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
10329
36266
1.56
281.59
4.1
2.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
12399
45337
1.52
281.51
4.6
3.6
ph
7.4
7.4
4.45
2277
10308
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5256
15404
1.81
281.31
1.9
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
9504
32741
1.58
280.96
1.7
1.7
pmol/l
36055188.5
35524604.6
0.03
8035
27128
(3017181) Myelocytes/100 leukocytes in Blood
4448
12368
1.90
279.74
4.7
3.6
%
0.8
1.0
2.05
1220
3304
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
2201
4604
2.49
276.95
2.2
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
5224
15384
1.80
274.89
2.9
2.4
%
1.8
1.7
4.10
4656
13667
(3000850) Epithelial cells [#/volume] in Urine
9410
32764
1.56
263.46
3.0
2.3
e6/l
5.0
6.0
7.33
8272
28273
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
3923
10737
1.92
257.35
2.7
2.2
ml/min/173m2
67.2
69.4
2.18
1584
4310
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
2980
7377
2.11
256.20
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10778
38941
1.51
254.11
5.1
3.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
4204
11879
1.87
250.53
4.8
3.7
%
0.1
0.1
1.78
1149
3086
(4010399)
3623
9741
1.95
249.77
1.5
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
4555
13253
1.82
247.60
8.5
7.9
g/l
122.3
122.6
0.50
4355
12741
(3021589) Normoblasts [#/volume] in Blood
19045
77099
1.41
247.51
10.6
8.7
e9/l
0.0
0.0
0.75
16323
61473
(3002582) Erythrocytes [#/volume] in Urine
12925
48704
1.47
247.01
3.7
2.8
e6/l
91.0
108.4
0.46
10457
35261
(3017143) Hepatitis C virus Ab [Presence] in Serum
6233
19988
1.66
241.23
1.7
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
2341
5395
2.26
238.46
6.0
4.5
%
1.7
1.7
0.91
2175
5019
(3002179) Metamyelocytes/100 leukocytes in Blood
4015
11410
1.85
234.34
4.3
3.5
%
0.6
0.6
0.20
887
2502
(3007930) Methemoglobin/Hemoglobin.total in Blood
2305
5316
2.25
234.31
6.1
4.5
%
0.9
0.9
0.71
2143
4940
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1972
4242
2.41
233.54
2.0
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
3994
11398
1.84
229.90
4.8
3.7
%
0.2
0.2
0.11
967
2743
(3044640) Blood type and Crossmatch panel - Blood
13296
50945
1.44
229.42
2.7
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
3480
9507
1.92
228.37
2.4
2.3
au/ml
26.9
22.9
0.88
159
722
(3020630) Protein [Mass/volume] in Serum or Plasma
3752
10562
1.86
225.05
2.6
2.3
g/l
66.6
66.6
0.00
3444
9683
(36660697) Celiac disease serology panel - Serum
4098
11914
1.81
222.05
1.2
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
1943
4253
2.37
221.56
7.0
5.0
mmol/l
1.3
1.3
0.04
1728
3652
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10131
37046
1.48
220.44
2.6
2.0
—
—
—
0
0
(3012544) pH of Venous blood
4527
13623
1.75
218.64
5.1
3.4
ph
7.4
7.4
0.12
26
88
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1598
3208
2.57
217.34
1.4
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
3194
8663
1.93
213.50
1.3
1.2
au/ml
45.9
48.9
0.25
115
423
(3029937) Albumin [Presence] in Urine by Test strip
12150
46282
1.44
213.10
4.6
3.3
estimate
0.0
0.0
0.64
4010
16349
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
1314
2401
2.82
212.41
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
5185
16373
1.67
210.43
1.3
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
4354
13136
1.74
207.87
5.1
3.4
kpa
5.9
5.8
1.95
4181
12782
(3002032) Base excess in Venous blood by calculation
4316
13079
1.74
202.66
5.1
3.3
mmol/l
1.9
1.8
1.29
3448
10810
(3030981) Hyaline casts [#/volume] in Urine by Automated count
2861
7604
1.96
202.26
3.1
2.4
e6/l
0.3
0.3
0.21
2784
7372
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1569
3270
2.48
197.91
1.5
1.4
ug/g
278.3
268.1
0.93
910
1886
(3037121) Protein [Mass/volume] in Urine
1834
4115
2.30
197.78
3.2
3.4
g/l
0.3
0.3
0.41
820
2042
(3017732) Neutrophils [#/volume] in Blood
3477
9958
1.83
196.58
2.9
2.5
e9/l
4.1
4.2
1.69
2801
8111
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
4283
13156
1.71
191.15
2.6
2.0
g/l
0.2
0.2
0.80
4007
12227
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
5182
16754
1.63
190.91
3.3
2.4
umol/l
8.0
9.2
2.86
4464
14397
(3002385) Erythrocyte distribution width [Ratio]
34740
158785
1.37
187.97
19.8
13.2
%
13.6
13.6
6.93
34122
154585
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2231
5562
2.08
186.91
2.0
1.9
u/l
39.2
39.0
0.10
2017
4935
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
28796
127988
1.34
185.08
3.3
3.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
2151
5328
2.09
183.13
1.9
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
8657
31684
1.47
182.56
3.2
2.4
mosm/kgh2o
546.4
560.1
5.91
7484
26722
(3030467) Casts [#/volume] in Urine by Automated count
11511
44454
1.41
181.55
3.6
2.7
e6/l
0.4
0.5
2.44
9135
31501
(3004588) Protein electrophoresis panel - Serum or Plasma
3025
8551
1.84
177.52
2.4
2.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
1717
3933
2.25
176.44
1.9
1.7
—
—
—
0
0
(4146454)
535
582
4.69
175.23
2.9
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
5468
18298
1.58
173.91
7.5
6.9
mmol/l
104.4
104.5
1.01
5331
17810
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
2222
5722
2.01
170.63
1.9
1.6
g/l
1.5
1.5
0.33
1902
4828
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
14130
57002
1.36
168.60
4.6
4.4
ug/l
3.1
3.1
0.03
12814
51308
(3009445) Proteinase 3 Ab [Units/volume] in Serum
2217
5730
2.00
168.53
1.7
1.5
u/ml
17.5
13.4
0.44
64
149
(3039000) Anion gap in Blood
1407
3009
2.41
168.00
8.0
5.8
mmol/l
11.2
11.3
0.27
1260
2671
(3018572) Chloride [Moles/volume] in Blood
1407
3010
2.41
167.89
8.0
5.8
mmol/l
105.1
105.1
0.13
1260
2672
(3015171) Extractable nuclear Ab [Units/volume] in Serum
2112
5408
2.02
164.55
1.3
1.2
u/ml
1.0
0.7
0.53
174
516
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
2012
5077
2.05
162.94
2.1
1.8
ug/l
2.1
2.5
0.60
1755
4521
(36304419) Bacteria [Presence] in Urine
11198
43768
1.38
161.05
3.4
2.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
1797
4366
2.12
160.25
1.6
1.6
titre
229.6
283.0
0.36
67
185
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
2593
7208
1.87
159.73
1.8
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1742
4194
2.14
158.86
3.0
2.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1284
2706
2.44
158.00
7.7
3.8
iu/ml
1394.9
3637.2
0.45
232
287
(3024354) Oxygen [Partial pressure] in Venous blood
3510
10842
1.69
151.87
4.4
2.8
kpa
4.7
4.6
2.47
3359
10505
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
738
1161
3.25
151.79
1.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
37883
177470
1.36
150.84
17.4
11.4
%
39.8
40.3
21.28
26829
136017
(3005988) Vibrio sp identified in Specimen by Organism specific culture
734
1156
3.25
150.72
1.5
1.3
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
1418
3202
2.28
150.27
1.4
1.3
mg/l
503.8
570.3
1.65
1332
3066
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
732
1154
3.24
150.08
1.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9548
36696
1.39
150.02
2.0
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
731
1154
3.24
149.57
1.5
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
1325
2909
2.34
149.44
1.3
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
1746
4314
2.09
149.11
2.5
2.2
ug/l
671.5
612.9
0.13
1624
4054
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
2718
7845
1.80
148.47
10.4
9.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
750
1213
3.16
147.91
1.5
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
396
384
5.25
145.71
38.1
32.3
ug/l
7.4
7.5
0.38
366
355
(3024522) Salmonella sp identified in Specimen by Organism specific culture
730
1177
3.17
144.65
1.5
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
3057
9207
1.73
144.54
3.2
3.5
pmol/l
4.5
4.6
3.16
2738
8334
(3014111) Lactate [Moles/volume] in Serum or Plasma
3879
12461
1.63
144.23
7.5
7.0
mmol/l
1.4
1.3
0.48
3646
12054
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1781
4496
2.04
143.79
1.6
1.6
iu/ml
13.2
2.2
0.56
351
930
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
510
637
4.08
142.97
2.8
2.1
e9/l
0.2
0.2
0.60
441
535
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
830
1467
2.90
141.83
1.7
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
522
670
3.97
141.56
2.7
2.1
e6/l
532.8
509.6
0.34
438
532
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
1270
2805
2.33
141.32
1.3
1.2
mmol/l
3.8
3.7
1.63
1178
2649
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
2390
6737
1.84
140.58
2.4
2.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
2475
7058
1.82
140.34
2.7
2.1
u/l
6161.5
6590.4
0.23
942
2890
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
1657
4114
2.07
139.64
1.8
1.6
g/l
1.2
1.2
0.85
1573
3949
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
996
1970
2.59
138.98
3.7
2.1
u/ml
1126.3
3839.4
1.58
63
103
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
670
1053
3.25
138.01
1.9
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
1241
2744
2.32
137.73
1.4
1.2
u/ml
270.1
253.1
1.07
776
1766
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9158
35418
1.38
136.75
1.7
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
2354
6686
1.82
135.08
4.3
2.9
mmol/l
25.1
25.3
0.81
2275
6472
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
1596
3985
2.06
132.47
1.9
1.6
g/l
0.2
0.2
1.88
1514
3813
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1351
3165
2.19
131.35
1.8
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
3067
9501
1.68
130.55
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
817
1511
2.77
129.04
7.2
5.4
mg/l
11.2
11.2
0.04
751
1382
(3028707) Methadone [Presence] in Urine by Screen method
1058
2240
2.42
128.82
3.2
2.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
634
1006
3.22
128.74
3.2
2.8
mg/l
64.8
56.4
0.20
478
703
(3011412) CD3 cells [#/volume] in Blood
675
1117
3.09
128.45
2.6
2.1
e9/l
1.2
1.1
2.00
406
750
(3048929) Epstein Barr virus Ab [Presence] in Serum
1976
5390
1.89
128.25
1.3
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
612
957
3.26
127.03
1.9
1.6
—
—
—
0
0
(44806118)
715
1240
2.95
126.12
1.7
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
425
506
4.28
126.08
1.4
1.6
ug/l
6.9
7.2
0.16
388
444
(44790049)
715
1241
2.94
125.95
1.7
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5767
20808
1.46
125.85
2.2
1.8
—
—
—
0
0
(44790048)
715
1242
2.94
125.79
1.7
1.4
—
—
—
0
0
(44790047)
715
1242
2.94
125.79
1.7
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
6970
26097
1.41
124.38
3.0
2.5
e6/l
1.1
1.3
1.27
4425
12967
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
6035
22037
1.44
123.50
1.9
1.6
%
1.5
1.4
22.17
5400
19596
(3015235) Bicarbonate [Moles/volume] in Capillary blood
1420
3482
2.10
123.38
3.5
2.9
mmol/l
24.5
24.8
1.89
1231
3192
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
1255
2928
2.20
123.16
1.5
1.4
e6/l
4581.3
988.7
0.67
1050
2282
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
6585
24457
1.42
122.80
3.3
2.6
e6/l
2.5
2.8
1.00
4063
11390
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1726
4562
1.95
122.67
2.3
2.1
g/l
7.3
7.4
0.60
1191
3541
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1722
4553
1.95
122.26
2.3
2.1
g/l
3.8
4.0
2.58
1134
3374
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1723
4559
1.95
122.07
2.3
2.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
1251
2926
2.19
122.04
1.5
1.4
e6/l
31.9
37.6
0.22
1006
2139
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7894
30316
1.38
121.04
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
7210
27286
1.40
120.59
2.8
3.2
mmol/l
2.4
2.4
10.92
6285
23649
(4024509)
533
787
3.45
120.24
1.6
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
1423
3537
2.07
119.39
2.1
2.0
mg/l
11.1
10.3
1.89
1323
3348
(3025941) Bacteria identified in Stool by Culture
2931
9181
1.65
119.31
1.3
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
1242
2931
2.17
118.58
1.6
1.3
u/ml
21.4
22.9
0.14
31
47
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
1252
2967
2.17
118.34
1.6
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
537
808
3.39
117.94
1.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
537
808
3.39
117.94
1.9
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
537
808
3.39
117.94
1.9
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
878
1777
2.53
117.11
2.0
1.7
titre
4.1
3.0
0.20
16
24
(3017446) Testosterone [Moles/volume] in Serum or Plasma
4065
13845
1.53
116.72
2.5
2.0
nmol/l
12.7
12.8
0.32
3644
12499
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1168
2711
2.21
115.99
1.7
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
566
899
3.21
114.79
3.5
2.9
%
57.9
58.8
0.32
373
612
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1420
3580
2.04
114.77
1.3
1.2
u/ml
38.8
36.5
0.10
75
230
(3004119) Hemoglobin [Mass/volume] in Venous blood
2810
8805
1.65
114.08
4.3
2.9
g/l
128.6
131.1
6.29
2746
8600
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
578
940
3.14
113.06
2.3
2.2
nmol/l
20.2
18.9
1.71
551
906
(3021879) Hepatitis B virus core Ab [Presence] in Serum
3887
13200
1.53
112.92
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
1765
4837
1.88
112.75
1.7
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
2100
6086
1.78
112.47
4.6
3.6
%
49.5
47.8
2.23
2069
6025
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1283
3135
2.10
112.40
1.9
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6260
23383
1.41
112.09
2.3
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
692
1269
2.78
110.97
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
953
2065
2.36
110.44
1.6
1.5
g/l
0.8
0.9
1.44
721
1429
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
898
1898
2.42
109.69
1.4
1.3
u/l
23.3
25.8
1.27
738
1617
(3009214) Lutropin [Units/volume] in Serum or Plasma
1818
5108
1.83
107.50
1.5
1.3
u/l
9.0
9.0
0.02
1504
4159
(3018405) Lactate [Moles/volume] in Arterial blood
1700
4675
1.87
107.40
4.0
4.0
mmol/l
1.3
1.4
2.43
1670
4599
(3007566) Smooth muscle Ab [Titer] in Serum
1490
3926
1.95
106.68
1.3
1.2
titre
79.2
129.8
2.13
146
396
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
1064
2462
2.21
106.40
1.3
1.2
titre
220.0
99.5
0.60
26
37
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1592
4305
1.90
105.74
2.3
2.1
g/l
3.0
3.1
3.53
1165
3491
(3034770) Mitochondria Ab [Titer] in Serum
1463
3850
1.95
105.10
1.3
1.2
titre
963.8
1189.1
0.43
39
102
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
470
701
3.42
104.58
2.9
2.2
e6/l
730.9
672.3
0.67
200
259
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11089
45624
1.30
104.45
4.2
3.9
%
22.0
21.9
0.40
4967
20979
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1306
3312
2.02
103.85
1.3
1.2
u/ml
8.1
10.2
0.42
216
452
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1292
3269
2.03
103.36
1.3
1.2
u/ml
5.1
10.3
0.91
140
301
(3041096) Erythrocytes [Presence] in Urine by Automated
12002
49969
1.29
102.95
3.6
2.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1058
2485
2.18
102.11
1.3
1.2
u/ml
22.4
14.8
—
8
45
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
2052
6090
1.74
101.21
1.1
1.1
u/ml
13.8
8.1
0.23
26
83
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1075
2563
2.15
100.06
1.3
1.2
u/ml
2.2
6.9
1.81
81
193
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
1133
2766
2.10
99.43
1.6
1.3
u/ml
113.8
104.6
1.48
252
669
(3010375) cycloSPORINE [Mass/volume] in Blood
345
422
4.16
99.28
28.5
23.6
ug/l
118.3
127.4
0.83
281
364
(3003338) MCHC [Mass/volume]
35205
166111
1.26
98.60
21.4
13.1
g/l
333.1
333.2
1.60
34964
164555
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
1345
3548
1.94
95.91
1.4
1.5
iu/ml
7.4
13.3
1.50
32
84
(1175426) CD3 cells/100 lymphocytes in Blood
541
936
2.95
95.88
2.2
1.9
%
73.4
72.3
0.76
514
907
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1549
4291
1.85
95.59
1.1
1.1
u/ml
5.8
4.7
0.33
152
727
(3004809) Band form neutrophils/100 leukocytes in Blood
885
1991
2.27
94.41
3.7
2.9
%
1.5
1.5
0.01
697
1622
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
1507
4177
1.85
92.81
5.1
2.8
mg/l
1.5
1.5
1.04
1387
3856
(3026389) Candida sp identified in Specimen by Organism specific culture
842
1868
2.30
92.68
1.4
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
711
1456
2.49
92.67
1.8
1.6
titre
2343.3
4869.3
0.49
24
30
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
515
884
2.97
92.48
2.2
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
2416
7685
1.62
91.98
1.1
1.1
titre
201.2
249.5
0.38
65
233
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
528
924
2.91
91.83
2.2
1.9
%
14.0
13.8
0.08
287
353
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1811
5362
1.74
89.90
1.7
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
389
567
3.49
89.47
2.8
2.5
%
39.3
39.3
0.00
166
176
(3023183) Ammonium ion [Moles/volume] in Plasma
1078
2692
2.05
89.23
3.1
2.4
umol/l
32.9
35.1
2.03
946
2199
(3000991) Gas panel - Venous blood
3601
12619
1.48
89.20
9.7
7.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1538
4351
1.81
88.81
2.4
2.1
g/l
10.3
10.4
0.53
1272
3702
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
535
963
2.83
88.70
1.1
1.1
mg/l
244.1
265.0
1.30
466
830
(3043409) Potassium [Moles/volume] in Arterial blood
1445
4023
1.84
87.74
4.3
4.2
mmol/l
3.9
3.9
1.20
1364
3670
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
10881
45492
1.27
87.51
1.8
1.6
mmol/l
1.4
1.4
6.76
9410
37319
(3045716) Anion gap in Serum or Plasma
289
339
4.33
87.36
2.5
2.5
mmol/l
9.2
9.7
0.71
211
192
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
546
1012
2.75
85.99
1.2
1.1
mg/l
36.2
45.7
4.66
458
810
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
306
384
4.05
85.48
2.2
1.7
%
28.6
29.2
0.24
290
365
(3045424) Erythrocytes [Presence] in Urine
920
2198
2.14
85.19
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
2544
8356
1.57
84.70
1.1
1.0
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
310
399
3.95
83.97
2.4
1.8
%
10.8
10.6
0.06
288
376
(4062490)
630
1276
2.52
83.97
1.4
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
94
15
31.77
83.87
1.1
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
10081
41948
1.27
83.62
4.7
3.4
%
90.4
90.2
0.32
9748
40954
(3028192) IgG subclass 2 [Mass/volume] in Serum
629
1277
2.51
83.44
1.4
1.3
g/l
2.9
3.0
1.29
456
755
(3044290) Cell count panel - Cerebral spinal fluid
1116
2895
1.97
83.37
1.5
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
2123
6699
1.63
83.27
3.9
3.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
628
1277
2.51
83.05
1.4
1.3
g/l
0.4
0.4
0.36
452
751
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
972
2405
2.07
82.41
1.6
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
627
1279
2.50
82.40
1.4
1.3
g/l
6.7
7.0
0.81
447
754
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
335
469
3.63
81.45
2.2
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
1439
4098
1.80
81.29
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
3838
13860
1.44
81.07
2.9
2.3
u/l
48.4
45.8
0.07
3253
11947
(3014765) Yersinia sp identified in Stool by Organism specific culture
1436
4091
1.80
81.02
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
947
2336
2.07
80.92
2.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
334
469
3.62
80.89
2.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
334
469
3.62
80.89
2.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
334
469
3.62
80.89
2.3
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
2070
6547
1.63
80.40
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1860
5725
1.67
80.19
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
2164
6926
1.61
80.15
5.7
3.6
mmol/l
24.0
24.2
1.43
1927
6231
(3042733) HLA Ab [Presence] in Serum
281
347
4.12
80.06
4.8
5.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1550
4541
1.75
79.69
3.6
2.9
u/ml
0.3
0.4
2.45
949
2452
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1461
4212
1.78
79.27
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1422
4067
1.79
79.20
1.2
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
389
617
3.21
79.20
1.5
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1654
4949
1.72
79.02
1.5
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
530
1018
2.65
78.25
3.3
2.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
1215
3321
1.87
78.01
1.4
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
1588
4715
1.73
77.95
3.5
2.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2691
9117
1.52
77.94
9.5
9.0
%
1.4
1.3
4.94
2673
9058
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
2682
9113
1.52
76.61
9.6
9.1
%
0.7
0.7
4.74
2661
9062
(3020891) Body temperature
1832
5690
1.65
76.29
5.0
4.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
2691
9164
1.51
76.06
9.6
9.2
%
94.1
93.8
1.35
2680
9132
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1355
3869
1.79
75.86
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
714
1612
2.26
75.60
2.5
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
681
1507
2.30
75.43
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
378
609
3.16
75.17
1.5
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
441
782
2.87
75.09
1.2
1.2
u/ml
44.6
55.7
0.24
22
31
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
636
1367
2.37
75.05
1.1
1.1
au/ml
32.1
8.1
—
5
9
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
151
103
7.44
74.59
6.6
6.7
%
67.5
73.4
0.97
118
75
(3008757) Leukocyte morphology finding [Identifier] in Blood
583
1206
2.46
74.52
4.4
3.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
434
766
2.88
74.49
1.2
1.2
u/ml
67.2
67.0
0.00
21
35
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
434
769
2.87
74.00
1.2
1.2
u/ml
45.8
47.0
0.03
29
43
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
622
1335
2.38
73.63
1.1
1.1
au/ml
72.7
63.2
—
7
11
(3022621) pH of Urine by Test strip
2810
9721
1.49
73.63
3.1
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
878
2187
2.05
73.17
1.5
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
264
336
3.99
72.58
2.1
1.4
u/ml
21988.2
1858.0
0.76
39
37
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
281
378
3.78
72.07
2.5
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
691
1573
2.24
71.81
1.6
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
921
2354
2.00
71.66
1.1
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
416
734
2.88
71.46
1.2
1.2
u/ml
8.2
8.1
0.00
32
41
(21494815) CD4 cells/100 lymphocytes in Specimen
527
1060
2.53
71.28
2.4
2.0
%
42.3
40.8
0.26
82
95
(4027681)
436
794
2.79
70.93
1.2
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
1219
3445
1.81
70.54
2.5
2.4
ug/min
129.4
115.9
0.35
744
2050
(3028626) Oxygen [Partial pressure] in Capillary blood
1250
3562
1.80
70.43
4.4
2.9
kpa
8.4
8.3
1.33
1162
3393
(40760888) Immunoglobulin light chains.free panel - Serum
1086
2959
1.88
70.39
3.4
3.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
3204
11480
1.44
70.16
1.2
1.2
iu/ml
134.6
149.9
1.09
1248
4537
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
578
1228
2.40
69.94
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
766
1842
2.12
69.84
4.9
4.6
umol/l
361.1
364.2
0.21
660
1575
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
2883
10140
1.47
69.48
1.9
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
682
1571
2.21
68.97
3.1
2.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
489
964
2.58
68.79
1.1
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
1752
5528
1.63
68.55
1.9
1.6
nmol/l
40.8
40.3
0.37
1707
5444
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
852
2151
2.02
68.53
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
488
967
2.57
67.98
1.2
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1322
3882
1.74
67.37
3.3
3.1
ratio
2.8
5.0
0.42
143
225
(3000475) Leukocytes [#/volume] in Synovial fluid
1143
3212
1.82
67.34
1.7
1.6
e6/l
13858.2
13676.2
0.03
874
2259
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1355
4008
1.73
67.33
3.4
3.1
mg/l
45.1
43.9
0.07
1144
2929
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1368
4061
1.72
67.13
2.3
2.4
g/l
0.9
0.9
0.04
1193
3476
(3037756) Immunofixation for Serum or Plasma
956
2536
1.93
67.05
1.7
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
760
1857
2.09
66.58
1.1
1.1
g/l
1.5
1.5
0.17
690
1696
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
363
618
2.99
66.22
2.8
2.7
ug/l
24.5
23.2
—
8
11
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
834
2116
2.01
66.21
1.5
1.3
—
—
—
0
0
(3000492) Spirometry study
4489
17202
1.35
66.18
1.5
1.4
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
295
439
3.42
66.05
2.2
1.5
umol/l
1.9
2.0
0.46
277
410
(3034860) Kappa light chains.free [Mass/volume] in Serum
1351
4020
1.72
65.75
3.4
3.1
mg/l
97.7
62.9
0.40
1136
2937
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1747
5579
1.61
65.10
1.3
1.3
miu/ml
222.5
229.0
0.27
757
2692
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
2052
6816
1.55
64.73
3.7
2.6
%
1.3
1.3
0.86
2044
6780
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
283
415
3.47
64.70
1.6
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
260
359
3.68
64.51
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
283
416
3.46
64.48
1.6
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
260
360
3.67
64.28
2.5
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
260
360
3.67
64.28
2.5
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
920
2444
1.92
64.26
1.6
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
263
368
3.63
64.12
2.5
1.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
596
1338
2.27
63.98
2.3
1.8
mg/l
25.3
28.9
0.67
131
417
(3024471) HLA-A [Type]
263
369
3.62
63.89
1.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
1266
3733
1.74
63.59
2.1
1.8
pmol/l
194.3
200.9
1.25
1201
3563
(3003181) Sodium [Moles/volume] in Urine
819
2110
1.98
62.38
1.4
1.4
mmol/l
66.8
62.7
1.53
651
1646
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1486
4613
1.65
61.89
3.1
2.3
g/l
3.5
3.7
4.74
1405
4407
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
1028
2870
1.83
61.83
1.3
1.2
u/ml
39.6
47.3
0.68
100
286
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
3842
14524
1.37
61.50
3.7
4.3
ug/l
24.6
31.4
0.51
3144
11575
(3021387) Prolactin [Units/volume] in Serum or Plasma
1992
6654
1.54
61.23
1.7
1.6
mu/l
308.2
298.2
0.46
1818
5916
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
2195
7492
1.51
61.09
9.9
9.7
mmol/l
24.2
24.4
1.74
2008
7037
(44816559) Phosphatidylethanol [Mass/volume] in Blood
989
2742
1.84
60.79
1.5
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
2001
6702
1.53
60.76
3.7
2.6
%
0.7
0.7
1.74
1935
6389
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
1041
2935
1.81
60.70
2.9
1.6
nmol/l
0.9
0.8
0.88
848
2581
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
3528
13181
1.38
60.66
2.1
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
803
2085
1.96
59.87
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1265
3802
1.70
59.40
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
1797
5909
1.56
59.18
2.5
1.8
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
321
544
3.00
59.06
1.6
1.3
umol/l
22.2
29.0
2.88
306
514
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1214
3617
1.72
58.80
2.1
2.2
g/l
0.0
0.0
0.80
1114
3307
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
627
1494
2.14
58.54
1.3
1.3
nmol/l
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
892
2429
1.87
57.94
2.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
319
547
2.96
57.59
1.7
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
488
1056
2.35
56.88
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
219
293
3.79
56.68
2.5
1.7
e6/l
197.7
1458.1
0.80
127
145
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
696
1750
2.03
56.66
1.2
1.3
nmol/l
0.2
0.2
0.51
34
113
(3016650) Hepatitis A virus Ab [Presence] in Serum
918
2543
1.84
56.59
1.1
1.1
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
111
73
7.71
56.34
1.0
1.0
u/ml
0.1
0.1
0.06
67
44
(3049717) Cytology report of Urine Cyto stain
1592
5148
1.58
56.29
2.6
2.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
762
1987
1.96
56.16
1.3
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
502
1107
2.31
56.16
1.5
1.4
promille
1.3
1.4
0.29
393
826
(3027923) C peptide [Moles/volume] in Serum or Plasma
324
571
2.88
55.90
1.5
1.6
nmol/l
1.1
1.2
1.40
260
481
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
208
272
3.88
55.43
3.5
2.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
691
1758
2.00
54.52
1.3
1.3
nmol/l
0.6
2.2
1.13
662
1686
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
739
1931
1.95
54.16
1.5
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
333
608
2.78
54.07
1.1
1.1
nmol/l
3.1
8.7
1.29
52
144
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
367
707
2.64
54.06
1.1
1.1
u/l
1.0
1.1
1.21
149
335
(3004716) Salmonella sp identified in Stool by Organism specific culture
2478
8877
1.43
53.92
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1216
3713
1.67
53.89
2.1
2.1
g/l
38.1
37.6
1.92
1039
3237
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
779
2079
1.91
53.74
1.2
1.2
u/l
36.5
28.1
0.85
687
1798
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
89
46
9.81
52.51
3.6
2.3
mg/l
2.2
2.5
0.40
77
37
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
661
1682
2.00
52.15
1.1
1.1
iu/ml
1.6
2.0
0.38
12
30
(3028433) Virus identified in Specimen by Culture
229
338
3.44
51.99
1.1
1.1
—
—
—
0
0
(3036489) Thrombin time
1721
5780
1.53
51.53
2.5
1.9
s
21.5
21.4
0.44
1462
5021
(3010503) CD19 cells [#/volume] in Blood
376
753
2.54
51.45
2.9
2.2
e9/l
0.2
0.3
0.27
361
736
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
359
702
2.60
51.44
2.9
3.6
nmol/l
119.5
125.8
0.11
353
691
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
153
167
4.65
50.28
6.2
4.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
706
1866
1.93
50.12
1.5
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5092
20629
1.28
49.47
1.7
1.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
234
365
3.25
49.08
1.3
1.2
%
111.6
110.3
0.24
210
327
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
248
404
3.12
48.69
1.3
1.2
g/l
0.3
0.3
0.95
200
313
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
443
986
2.29
48.62
1.3
1.2
mmol/l
2.0
2.1
0.46
412
919
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
236
374
3.20
48.34
2.6
2.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
1505
4985
1.54
47.95
2.7
2.0
%
92.9
91.6
1.22
1405
4603
(3016244) Insulin [Units/volume] in Serum or Plasma
371
765
2.47
47.93
3.2
3.0
mu/l
27.4
28.1
0.11
349
732
(3042111) Morphology [Interpretation] in Bone marrow Narrative
760
2100
1.84
47.28
1.7
1.6
—
—
—
0
0
(4198724)
298
552
2.74
47.24
2.0
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
545
1341
2.07
47.04
3.1
3.3
nmol/l
5.4
9.1
0.42
525
1308
(3021901) Oxygen saturation in Capillary blood
953
2825
1.72
47.03
3.2
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
3900
24982
0.77
46.55
1.3
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1363
4445
1.57
46.47
3.1
2.2
%
181.4
187.9
1.75
1289
4219
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
389
834
2.37
46.36
1.2
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
428
959
2.27
46.30
1.1
1.1
mg/l
283.6
286.5
0.27
389
870
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
391
841
2.36
46.28
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
209
315
3.37
46.13
1.5
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6631
27938
1.23
45.57
1.5
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
334
673
2.52
45.23
1.3
1.2
%
58.1
67.6
0.95
43
86
(3000764) Benzodiazepines [Presence] in Urine
2233
8102
1.41
45.17
2.3
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
497
1202
2.10
44.84
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
2251
8197
1.41
44.60
2.3
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
330
666
2.52
44.56
1.5
1.4
u/l
5.7
5.9
0.15
283
567
(3016879) Cocaine [Presence] in Urine
2087
7499
1.43
44.54
2.4
1.7
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
466
1102
2.15
44.45
1.9
2.1
g/24h
1.2
0.9
0.31
35
68
(3027008) Opiates [Presence] in Urine
2244
8173
1.41
44.41
2.3
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
610
1603
1.94
44.09
1.3
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
1041
3219
1.65
44.02
1.1
1.1
u/ml
6.3
5.8
0.38
572
1577
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
759
2147
1.80
43.88
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
274
508
2.74
43.42
2.7
1.6
umol/l
134.5
114.0
0.45
145
249
(3024928) Oxygen saturation in Venous blood
975
2975
1.67
43.36
4.6
2.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
408
924
2.24
43.12
1.3
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
358
766
2.38
42.90
3.0
1.7
%
97.4
97.8
0.07
337
714
(3047007) Chlamydophila sp Ab [Presence] in Serum
762
2178
1.78
42.60
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
219
361
3.08
42.29
1.7
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
401
913
2.23
41.88
1.9
1.6
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
269
505
2.70
41.70
1.1
1.1
u/ml
8.7
7.9
0.10
55
86
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
427
1003
2.16
41.44
1.4
1.2
u/ml
1.3
1.4
0.10
219
329
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
323
674
2.43
40.82
11.4
11.8
mmol/l
0.6
0.6
0.76
298
608
(3008037) Lactate [Moles/volume] in Venous blood
1010
3164
1.63
40.63
3.5
2.8
mmol/l
1.6
1.6
0.88
985
3101
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1073
3413
1.60
40.62
2.2
2.2
g/l
0.0
0.0
0.44
977
3113
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
867
2614
1.69
40.32
1.1
1.1
iu/ml
241.0
749.8
0.61
205
570
(3027944) Amphetamines [Presence] in Urine
2204
8140
1.39
40.17
2.2
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
1131
3657
1.58
40.01
1.1
1.1
u/ml
1.8
1.9
0.14
517
1397
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
505
1287
2.00
39.80
1.6
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
786
2315
1.73
39.73
3.0
2.9
nmol/l
0.8
0.8
0.05
556
1830
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
840
2522
1.70
39.67
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1150
3745
1.57
39.47
1.9
1.9
iu/l
4.3
23.8
0.71
426
1423
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
103
97
5.38
39.31
1.0
1.1
u/ml
0.5
5.7
0.58
57
43
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1055
3372
1.60
39.16
2.2
2.2
g/l
0.0
0.0
0.00
972
3105
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
125
145
4.37
38.56
1.7
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
482
1225
2.00
38.30
1.3
1.3
nmol/l
1.5
1.4
0.61
436
1112
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
576
1561
1.88
38.12
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
271
538
2.56
37.88
1.9
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
425
1040
2.08
37.32
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
267
531
2.55
37.21
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
506
1324
1.94
37.11
1.5
1.4
mosm/kgh2o
280.7
279.6
0.49
397
1045
(3014271) Vancomycin [Susceptibility]
234
436
2.72
36.84
3.1
2.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
143
193
3.76
36.80
2.0
2.0
umol/l
16.7
17.5
0.32
143
193
(40757373) Influenza virus identified in Isolate
150
212
3.59
36.33
1.8
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
393
943
2.12
36.28
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
394
947
2.11
36.22
1.1
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
345
785
2.23
36.17
1.6
1.5
u/ml
26.6
25.9
0.08
68
157
(3006270) Folate [Moles/volume] in Blood
462
1182
1.99
36.09
1.2
1.1
nmol/l
353.9
392.8
3.20
391
987
(3039162) Centromere protein B Ab [Units/volume] in Serum
608
1713
1.81
35.70
1.3
1.2
u/ml
63.5
51.1
0.49
42
112
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
120
144
4.22
35.66
1.5
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
98
98
5.07
35.36
1.1
1.1
u/ml
0.1
1.2
0.80
63
40
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
275
571
2.45
35.20
1.2
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
159
240
3.36
35.16
1.3
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
216
396
2.77
35.04
1.4
1.4
pmol/l
14.2
15.0
1.07
186
343
(3032057) Clostridioides difficile [Presence] in Stool
132
174
3.85
35.03
1.8
1.8
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
343
791
2.20
34.88
1.4
1.2
umol/l
5.1
5.5
1.10
317
744
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
113
133
4.31
34.35
2.5
2.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
301
667
2.29
33.56
1.0
1.0
ng/l
41.5
41.9
0.05
203
518
(3008401) Mugwort IgE Ab [Units/volume] in Serum
965
3137
1.57
33.42
1.1
1.1
u/ml
1.2
1.2
0.00
442
1248
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
530
1461
1.84
33.37
1.3
1.3
nmol/l
19.8
22.0
—
6
8
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
305
683
2.27
33.22
1.1
1.1
miu/ml
1440.2
1455.5
0.08
305
683
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
300
668
2.28
33.10
1.0
1.0
ng/l
788.5
719.3
1.45
196
503
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
659
1947
1.72
33.04
3.6
2.5
u/ml
2298.8
697.8
0.54
633
1802
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1380
4858
1.45
32.83
1.9
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
690
2070
1.70
32.77
1.7
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
297
662
2.28
32.70
1.0
1.0
ng/l
312.0
330.2
0.42
204
523
(3023323) Follitropin [Units/volume] in Serum or Plasma
2229
8526
1.34
32.50
1.5
1.3
iu/l
23.8
27.2
5.22
1931
7226
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
226
444
2.58
32.33
3.2
2.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
390
977
2.03
32.31
1.2
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
210
398
2.68
32.14
1.1
1.1
u/ml
3.2
7.2
0.79
109
230
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
151
235
3.26
31.98
1.2
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
373
924
2.05
31.83
1.6
1.4
u/l
12.8
12.4
0.45
362
899
(3011985) Renin [Units/volume] in Plasma
641
1901
1.72
31.73
1.6
1.5
mu/l
55.4
67.5
0.78
575
1700
(3010144) Erythrocytes [#/volume] in Synovial fluid
470
1267
1.89
31.70
1.4
1.3
e6/l
77684.3
90582.3
0.18
317
872
(3008116) Ketones [Moles/volume] in Urine by Test strip
160
261
3.11
31.56
1.7
1.2
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
88
89
5.01
31.45
1.0
1.1
u/ml
0.2
1.1
0.85
59
36
(4015189)
151
238
3.22
31.40
2.4
2.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
141
213
3.36
31.21
1.1
1.2
u/ml
1.6
12.3
2.69
101
152
(1761482) Bacteria [#/volume] in Urine by Culture
1156
3974
1.48
31.02
4.5
3.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
270
591
2.32
30.98
1.6
1.5
nmol/l
3.6
4.9
0.54
212
496
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
753
2350
1.63
30.85
1.3
1.2
u/ml
4.3
3.8
0.39
326
1072
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
121
166
3.70
30.57
2.1
2.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
290
660
2.23
30.49
2.2
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
279
625
2.27
30.42
1.4
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
201
384
2.66
30.35
1.1
1.0
u/ml
6.0
10.9
0.83
19
46
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
3452
14134
1.25
29.95
4.0
3.7
mmol/l
1.2
1.2
0.13
3054
12046
(4306422)
752
2365
1.62
29.91
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
248
531
2.37
29.87
1.9
2.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
353
879
2.04
29.76
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
267
593
2.29
29.69
1.8
1.7
%
143.0
143.0
0.00
250
558
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
397
1036
1.95
29.47
1.2
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
924
3063
1.54
29.43
3.7
2.9
mmol/l
7.7
7.7
0.10
907
3007
(3048879) Bone marrow aspiration report
147
238
3.13
29.38
2.2
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
226
467
2.46
29.32
2.3
2.5
ug/l
1.1
1.2
0.13
206
437
(4034850)
954
7089
0.67
29.13
11.6
8.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
506
1438
1.79
29.00
1.8
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
617
1863
1.68
28.69
1.6
1.5
%
57.8
57.5
0.05
408
1161
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
62
47
6.68
28.54
3.2
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
760
2429
1.59
28.34
1.1
1.1
au/ml
15.7
11.8
0.38
40
195
(3018133) Calcium [Moles/volume] in Urine
119
171
3.53
28.30
2.0
1.7
mmol/l
2.6
2.6
0.03
104
154
(3006576) Bicarbonate [Moles/volume] in Blood
229
491
2.37
27.55
6.6
5.5
mmol/l
25.1
25.1
0.03
213
433
(44813793)
408
1101
1.88
27.52
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
255
575
2.25
27.45
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
497
1429
1.77
27.44
1.4
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
295
708
2.12
27.38
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
876
2917
1.53
27.37
3.7
2.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
389
1037
1.91
27.21
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
98
125
3.97
27.20
1.2
1.3
%
51.7
54.5
0.17
46
71
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
542
1604
1.72
27.12
1.1
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
457
1286
1.81
27.09
2.4
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
156
277
2.86
26.89
7.5
6.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
256
584
2.22
26.85
6.1
4.1
mg/l
1707.0
4360.8
0.93
185
400
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
73
72
5.14
26.80
1.6
1.7
mg/l
1.3
1.9
0.44
49
43
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
769
2504
1.56
26.54
1.3
1.2
u/ml
3.7
3.8
0.06
267
895
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
88
105
4.25
26.44
1.0
1.1
u/ml
1.1
3.7
1.51
64
86
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
341
877
1.97
26.43
1.5
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
94
119
4.00
26.35
2.5
3.8
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
143
246
2.95
26.01
1.4
1.3
%
27.0
22.1
0.99
114
203
(40757494) Bilirubin.total [Moles/volume] in Blood
275
656
2.13
25.94
2.5
2.1
umol/l
19.0
49.9
2.88
26
79
(3010726) Horse dander IgE Ab [Units/volume] in Serum
921
3139
1.49
25.84
1.1
1.1
u/ml
2.5
2.4
0.09
252
780
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
1299
4730
1.40
25.74
2.0
1.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
173
334
2.63
25.71
7.1
6.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
256
596
2.18
25.63
2.4
2.3
umol/l
52.0
52.1
0.01
224
488
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
1.4
1.6
0.05
43
45
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
1.6
2.1
0.35
51
50
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
2.1
3.3
0.62
46
43
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
1.4
1.1
0.26
39
41
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
0.9
0.6
0.30
46
44
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
0.9
2.0
0.93
43
43
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
1.9
3.8
1.03
48
51
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
1.4
2.2
0.58
48
48
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
70
70
5.07
25.37
1.6
1.7
mg/l
4.4
3.8
0.20
43
44
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
778
2567
1.54
25.37
1.3
1.3
mmol/l
7.2
7.0
1.14
550
1832
(1761868) Lipid panel - Serum or Plasma
13868
76119
0.89
25.33
2.8
2.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
584
1799
1.65
25.27
1.4
1.3
pmol/l
355.9
276.9
0.80
433
1432
(3006184) Hemoglobin [Mass/volume] in Capillary blood
1103
3915
1.44
25.20
2.2
2.2
g/l
131.5
131.3
0.08
808
3054
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
270
650
2.11
24.92
1.3
1.2
titre
70.9
104.6
0.39
22
48
(3044242) Glucose [Moles/volume] in Arterial blood
260
620
2.13
24.58
2.1
2.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
126
208
3.07
24.52
7.8
6.7
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
43
24
9.07
24.38
3.9
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
710
5390
0.66
24.24
1.4
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
2563
10386
1.26
24.20
8.8
6.4
mmol/l
24.7
24.7
0.19
2537
10280
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
275
675
2.07
24.19
1.8
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1374
5107
1.37
24.10
3.3
3.6
u/ml
2314.8
2749.5
0.07
1175
4392
(3037556) Urate [Mass/volume] in Serum or Plasma
163
316
2.62
24.07
1.3
1.3
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
60
54
5.63
24.01
1.0
1.0
u/ml
0.6
2.2
0.38
52
39
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
351
944
1.89
23.99
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
714
5399
0.66
23.90
1.4
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
276
682
2.05
23.87
1.3
1.2
titre
649.4
498.2
0.15
18
57
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
452
1319
1.74
23.82
4.3
5.1
u/ml
77.5
98.3
0.37
134
459
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
48
33
7.37
23.79
6.8
4.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
41
22
9.44
23.79
4.0
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
528
1611
1.67
23.72
1.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
426
1225
1.77
23.60
4.2
3.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
735
5512
0.67
23.59
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
3477
21008
0.83
23.34
1.7
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
160
313
2.59
23.25
1.4
1.5
ug/l
8.9
9.1
0.17
160
313
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
373
1036
1.83
23.14
2.2
1.6
mg/l
4.2
3.8
0.77
353
979
(3016228) CD19 cells/100 cells in Blood
240
569
2.14
23.06
2.3
2.0
%
8.5
8.3
0.07
229
558
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
256
624
2.08
22.95
1.7
1.5
iu/ml
2341505.1
1741640.9
0.23
16
38
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
331
887
1.89
22.90
1.4
1.4
mmol/l
5.7
5.6
0.71
317
838
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
124
212
2.96
22.85
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
139
256
2.75
22.58
1.4
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
155
303
2.59
22.57
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
703
2330
1.53
22.53
1.1
1.1
%
116.3
117.7
0.54
638
2097
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
7431
33432
1.15
22.27
2.9
2.8
ug/l
0.7
0.8
9.26
4788
20562
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
180
382
2.39
22.25
1.1
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
147
282
2.64
22.19
1.3
1.2
umol/l
16.7
16.6
0.02
128
250
(3009015) Lactate [Moles/volume] in Synovial fluid
75
91
4.18
22.18
1.2
1.3
mmol/l
6.1
5.9
0.08
32
49
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
4841
21105
1.18
21.92
1.7
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
127
226
2.85
21.92
1.7
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
463
1394
1.69
21.90
1.2
1.2
u/l
61.4
71.0
0.91
299
967
(3034274) Bile acid [Moles/volume] in Serum --fasting
729
2456
1.51
21.69
2.3
2.2
umol/l
7.3
6.3
0.46
527
1801
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
725
2442
1.51
21.60
1.1
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
569
1814
1.59
21.58
2.6
2.1
mmol/l
4.1
4.1
0.29
564
1797
(3035285) Chloride [Moles/volume] in Venous blood
569
1814
1.59
21.58
2.6
2.1
mmol/l
105.4
105.6
0.58
564
1796
(3016038) Potassium [Moles/volume] in Urine
304
809
1.91
21.50
1.2
1.2
mmol/l
33.0
35.4
1.00
261
706
(3051651) Icteric interference index of Serum or Plasma
309
827
1.90
21.50
3.7
3.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
84
115
3.70
21.43
1.6
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
5059
22179
1.17
21.37
1.3
1.3
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
230
554
2.11
21.30
2.6
2.4
au/ml
172.4
144.7
0.27
37
77
(3022229) Phosphate [Moles/volume] in Urine
53
48
5.59
21.13
1.8
1.7
mmol/l
22.2
21.5
0.05
42
35
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
345
963
1.82
21.12
20.4
16.3
nmol/l
1453.8
2966.0
0.47
330
927
(3051593) INR in Capillary blood by Coagulation assay
222
529
2.13
21.12
8.0
13.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
247
615
2.04
21.02
3.1
2.9
mg/l
6.7
8.5
4.11
204
462
(3011841) English Walnut IgE Ab [Units/volume] in Serum
82
112
3.71
20.99
1.0
1.1
u/ml
0.7
11.2
1.61
60
91
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
108
179
3.06
20.97
1.3
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
331
915
1.84
20.90
14.3
11.3
nmol/l
815.4
1922.4
0.51
314
879
(3034092) Cytoplasmic Ig cells/100 cells in Blood
104
169
3.12
20.83
8.7
7.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
229
558
2.08
20.62
2.3
2.0
—
—
—
0
0
(4268621)
514
1618
1.61
20.55
2.5
2.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
151
307
2.49
20.43
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
271
706
1.95
20.41
1.6
1.6
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
154
317
2.46
20.32
1.3
1.2
nmol/l
105.7
125.1
0.87
119
223
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
253
644
1.99
20.32
4.0
3.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
210
499
2.13
20.14
1.7
1.7
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
60
65
4.68
20.14
1.1
1.3
%
27.6
15.8
0.63
19
18
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
223
543
2.08
20.13
2.2
1.8
mg/l
9.4
9.5
0.14
189
411
(3013727) Leukocytes other/100 leukocytes in Blood
202
473
2.17
20.08
4.1
3.3
%
53.6
52.4
0.27
191
458
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
63
72
4.43
19.97
1.0
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
808
2830
1.45
19.90
3.1
3.9
u/ml
548.1
1016.6
0.59
741
2589
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
98
158
3.14
19.89
1.6
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
932
3353
1.41
19.87
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
932
3355
1.41
19.81
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1483
5750
1.31
19.73
1.4
1.4
—
—
—
0
0
(4094501)
1118
4158
1.37
19.61
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
112
198
2.87
19.60
2.6
2.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
142
287
2.51
19.46
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
392
1166
1.71
19.44
1.8
1.9
mmol/l
6.8
6.7
0.08
243
934
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
145
297
2.47
19.36
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
2304
14233
0.81
19.24
1.4
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
283
765
1.88
19.18
1.7
1.7
u/field
2.8
2.4
0.32
186
606
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
201
480
2.12
19.08
1.8
1.9
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
386
1150
1.70
19.05
1.2
1.2
titre
195.4
149.7
0.17
13
34
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
194
458
2.15
18.94
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
269
719
1.90
18.86
1.1
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
185
429
2.19
18.86
1.7
1.6
au/ml
90.6
132.7
0.52
25
50
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
550
1798
1.55
18.83
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
386
1154
1.70
18.82
1.2
1.2
titre
126.8
206.0
1.24
66
179
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
146
305
2.43
18.74
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
152
325
2.37
18.59
1.1
1.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
48
45
5.40
18.58
11.5
9.7
e6/l
379.5
211.1
0.35
34
30
(3001964) Herpes simplex virus Ag [Presence] in Specimen
175
399
2.22
18.57
1.9
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
112
205
2.77
18.49
1.1
1.1
umol/24h
0.7
0.9
0.41
60
107
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
90
145
3.14
18.32
1.1
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
147
312
2.39
18.27
2.0
1.5
u/l
32.8
33.6
0.03
137
276
(4035726)
3319
14225
1.19
18.19
1.4
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
192
460
2.12
18.11
1.9
1.7
%
170.3
161.6
0.41
180
424
(3033705) Calcium.ionized [Moles/volume] in Venous blood
548
1808
1.54
18.04
2.6
2.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
174
401
2.20
18.03
1.4
1.4
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
53
57
4.71
17.96
1.0
1.1
u/ml
18.9
22.3
0.11
41
44
(3016750) Collection duration of Urine
310
882
1.78
17.94
2.3
1.9
min
497.6
501.8
0.30
237
592
(3042631) Mycobacterium sp identified in Specimen
619
2101
1.50
17.89
2.9
2.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
114
215
2.69
17.86
1.2
1.3
u/ml
1.1
6.8
1.03
27
48
(3004775) Volume in Urine collected for unspecified duration
399
1222
1.66
17.83
2.4
2.0
ml
674.2
698.5
0.52
283
749
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
245
647
1.92
17.83
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
1038
3879
1.36
17.72
1.6
1.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
155
343
2.29
17.63
1.3
1.3
%
39.1
38.4
0.07
97
249
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
202
505
2.03
17.12
1.1
1.1
ng/l
755.0
519.2
0.29
28
135
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
405
1264
1.63
16.86
1.3
1.3
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
84
137
3.11
16.82
4.1
6.8
g/mol
75.3
66.6
0.10
75
130
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
183
444
2.09
16.77
1.1
1.1
%
88.8
92.1
0.57
91
196
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
211
541
1.98
16.72
1.5
1.4
%
73.8
72.8
0.37
197
519
(40768441) Liver Pathology biopsy report
342
1023
1.70
16.71
1.6
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
1197
4614
1.32
16.66
3.4
3.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
184
449
2.08
16.62
1.1
1.2
%
113.2
106.8
1.11
166
405
(3028679) Herpes simplex virus Ab [Presence] in Serum
294
844
1.77
16.57
1.2
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
149
334
2.26
16.50
1.3
1.2
g/l
40.6
40.7
0.01
79
186
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
65
90
3.66
16.44
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
211
545
1.96
16.40
1.2
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
247
674
1.86
16.37
1.1
1.1
u/l
31.6
23.4
0.57
182
528
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
183
449
2.07
16.32
1.3
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
247
675
1.86
16.30
1.1
1.1
u/l
96.7
83.1
0.84
194
543
(3014133) Dog dander IgE Ab [Units/volume] in Serum
759
2732
1.41
16.24
1.1
1.0
u/ml
4.3
4.7
0.32
332
1031
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
89
154
2.93
16.23
1.1
1.2
u/ml
0.3
0.6
0.43
55
87
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
205
526
1.98
16.23
1.5
1.4
mu/l
459.8
855.2
1.10
191
504
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
232
623
1.89
16.14
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
232
623
1.89
16.14
1.5
1.3
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
25
11
11.51
16.11
1.2
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
178
435
2.07
16.04
1.1
1.2
%
90.0
92.6
0.31
89
196
(3003694) ABO and Rh group [Type] in Blood
11651
54716
1.10
16.01
1.5
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
74
115
3.26
15.96
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
81
134
3.06
15.89
1.5
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
56
71
3.99
15.84
1.2
1.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
13
10.13
15.71
6.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
1059
4048
1.33
15.64
3.8
3.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
326
982
1.68
15.57
1.1
1.2
ratio
1.1
1.1
0.78
89
453
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
137
304
2.28
15.55
1.1
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
351
1079
1.65
15.55
1.2
1.1
u/ml
78.8
81.9
—
5
12
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
324
975
1.69
15.54
1.1
1.1
iu/ml
9.0
9.0
0.01
60
287
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
82
140
2.97
15.32
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
157
372
2.14
15.31
1.4
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
104
205
2.57
15.09
1.1
1.1
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
56
74
3.83
15.07
1.1
1.0
u/ml
0.2
0.3
0.22
26
24
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
508
1717
1.50
15.07
1.2
1.1
%
94.4
96.9
1.13
470
1612
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
383
1217
1.60
14.91
2.1
2.0
u/field
1.9
2.0
0.06
173
492
(3003434) Protein [Mass/volume] in Pleural fluid
556
1920
1.47
14.87
1.6
1.4
g/l
32.0
33.6
2.12
502
1728
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1850
7643
1.23
14.75
2.0
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
84
149
2.86
14.75
1.2
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
93
175
2.69
14.72
1.5
1.2
ng/l
53.7
98.7
1.18
65
116
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
491
1657
1.50
14.69
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
773
2844
1.38
14.62
1.5
1.4
nmol/l
0.4
0.4
0.41
603
2266
(3038177) Helicobacter pylori Ab [Presence] in Serum
772
2845
1.38
14.46
1.2
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
88
163
2.74
14.34
1.1
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
238
671
1.80
14.32
1.6
1.5
mmol/24h
5.9
5.6
0.15
25
43
(3021788) Differential panel - Synovial fluid
765
2821
1.38
14.28
1.6
1.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
123
273
2.28
14.01
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
123
273
2.28
14.01
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
123
273
2.28
14.01
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
123
273
2.28
14.01
1.1
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
339
1062
1.62
14.01
1.4
1.4
umol/l
12.3
12.0
0.33
319
1015
(3034426) Prothrombin time (PT)
180
466
1.96
13.99
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
133
306
2.20
13.96
2.5
2.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
492
1681
1.49
13.90
1.6
1.4
e6/l
2342.2
2724.5
0.36
379
1140
(1002224) Polysomnography panel
1910
7978
1.22
13.73
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
652
2359
1.40
13.64
1.4
1.4
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
73
125
2.96
13.62
1.2
1.3
u/l
501.6
73.2
0.53
54
90
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
243
705
1.75
13.34
6.8
4.5
u/ml
775.0
1496.1
0.31
55
101
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
184
490
1.90
13.23
1.1
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
45
56
4.07
13.07
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
70
120
2.95
13.06
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
231
665
1.76
13.03
2.0
2.3
ug/l
140.2
294.6
0.40
214
632
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1195
4764
1.28
13.02
1.2
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1869
7834
1.22
12.99
2.8
3.3
u/ml
38.4
49.9
1.91
1797
7588
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
339
1086
1.58
12.85
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
336
1075
1.59
12.81
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
336
1075
1.59
12.81
1.2
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
109
239
2.31
12.80
1.3
1.1
—
—
—
0
0
(44806071)
86
168
2.59
12.77
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
233
677
1.75
12.75
4.1
3.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
336
1077
1.58
12.71
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
338
1085
1.58
12.71
1.2
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
383
1266
1.54
12.69
1.4
1.3
u/l
366.8
510.7
1.86
362
1200
(40761536) Microorganisms panel - Urine sediment
3274
18937
0.87
12.67
4.5
3.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
280
858
1.66
12.67
6.0
7.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
338
1086
1.58
12.66
1.2
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
177
473
1.90
12.62
2.8
2.8
umol/l
28.4
28.4
0.01
133
358
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
74
134
2.80
12.61
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
281
865
1.65
12.50
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
996
3902
1.30
12.44
1.3
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
665
2455
1.38
12.40
1.1
1.1
u/ml
3.2
2.8
0.31
290
1400
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
172
459
1.90
12.33
1.1
1.2
%
20.2
20.9
0.04
24
82
(3010370) Gastrin [Moles/volume] in Serum or Plasma
87
175
2.52
12.24
2.0
1.6
pmol/l
50.8
54.3
0.10
76
146
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
610
2227
1.39
12.17
1.1
1.0
u/ml
0.7
0.6
0.19
159
411
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
869
3353
1.32
12.14
1.9
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
253
764
1.68
12.11
1.2
1.1
u/ml
19.7
18.9
0.02
30
70
(3023420) DNA double strand Ab [Units/volume] in Serum
484
1698
1.45
12.05
1.7
1.5
iu/ml
26.0
29.3
0.22
31
62
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
58
93
3.16
12.05
1.1
1.0
u/ml
1.0
0.8
0.13
40
63
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
253
766
1.67
12.00
1.3
1.2
u/l
98.0
86.2
0.68
224
662
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
80
156
2.60
11.95
1.2
1.1
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
27
22
6.21
11.87
3.9
3.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
244
734
1.69
11.86
1.2
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
270
836
1.64
11.78
1.5
1.5
u/l
5.0
6.9
1.25
112
421
(3041672) Baker's yeast Ab [Presence] in Serum
37
43
4.36
11.65
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
97
212
2.32
11.53
1.3
1.3
mu/l
152.3
66.3
0.54
70
167
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
62
107
2.93
11.49
2.0
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
181
504
1.82
11.45
2.1
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
4707
21403
1.12
11.45
1.5
1.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
314
1017
1.57
11.43
1.3
1.3
u/l
12.5
14.4
1.13
284
958
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
77
151
2.58
11.40
1.5
1.5
nmol/l
6.4
460473.4
1.73
64
129
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
54
86
3.18
11.35
1.0
1.1
u/ml
7.8
8.7
0.10
42
47
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
968
6203
0.79
11.34
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
971
6218
0.79
11.31
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
970
6212
0.79
11.30
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
965
6180
0.79
11.25
1.4
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
174
482
1.83
11.20
1.2
1.1
g/l
0.2
0.2
0.01
14
32
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
194
556
1.77
11.19
1.1
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
33
36
4.64
11.13
1.3
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
47
69
3.45
11.12
1.6
2.0
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
55
90
3.09
11.11
1.5
1.3
ml/s/173m2
1.0
1.2
0.70
40
54
(3051611) Lipemic interference index of Serum or Plasma
434
1516
1.45
11.10
3.6
3.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
691
2615
1.34
11.08
1.1
1.0
u/ml
6.0
5.8
0.08
320
1051
(3030313) Adrenal Ab [Titer] in Serum
63
113
2.82
10.97
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
106
247
2.17
10.92
1.5
1.3
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
77
155
2.52
10.87
1.6
2.1
mmol/l
1.3
1.6
0.27
45
123
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
241
742
1.65
10.80
1.3
1.2
u/l
20.1
24.1
0.78
210
633
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
81
170
2.41
10.53
2.5
1.6
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
45
67
3.40
10.46
1.1
1.1
u/l
1.6
4.4
—
6
17
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
232
714
1.65
10.43
1.0
1.1
%
95.9
95.9
0.00
194
549
(3035947) Staphylolysin Ab [Units/volume] in Serum
239
742
1.63
10.39
1.2
1.1
iu/ml
4.1
4.3
0.09
13
64
(3007700) Barley IgE Ab [Units/volume] in Serum
42
60
3.54
10.33
1.0
1.0
u/ml
1.3
0.2
0.80
20
29
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
54
92
2.97
10.27
2.1
2.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
48
76
3.20
10.22
1.1
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
92
208
2.24
10.20
1.7
1.4
ug/l
0.4
0.5
1.53
68
140
(3001686) Cold agglutinin [Titer] in Serum or Plasma
95
218
2.21
10.18
1.4
1.2
titre
41.4
268.1
—
8
22
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
116
289
2.03
10.15
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
512
1875
1.39
10.13
1.8
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
94
216
2.20
10.05
1.6
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
881
3499
1.28
10.01
1.4
1.4
pmol/l
105.8
131.3
1.32
854
3431
(4211845)
256
817
1.59
9.99
3.7
2.5
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
35
45
3.94
9.86
1.0
1.0
u/ml
0.2
0.4
0.30
20
14
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
295
977
1.53
9.82
1.8
1.8
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
116
293
2.01
9.81
1.2
1.2
%
72.0
79.7
0.62
35
75
(3014891) Appearance of Pleural fluid
72
148
2.46
9.80
2.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
61
115
2.69
9.78
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
48
79
3.08
9.66
1.6
1.6
umol/l
44.9
43.0
0.13
48
79
(3023487) Leukocytes [#/volume] in Peritoneal fluid
162
463
1.77
9.52
2.6
1.6
e6/l
664.9
4502.4
0.97
119
285
(3017315) Amylase [Enzymatic activity/volume] in Urine
270
884
1.55
9.48
1.4
1.2
u/l
284.0
389.5
0.98
243
837
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
154
435
1.79
9.41
1.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
211
652
1.64
9.40
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
362
1264
1.45
9.37
1.9
1.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
61
118
2.62
9.35
1.1
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
91
213
2.16
9.35
1.7
1.3
nmol/l
0.2
0.3
0.71
67
143
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
34
45
3.83
9.26
1.1
1.0
u/ml
0.1
0.4
0.34
18
15
(3020874) Milk IgE Ab [Units/volume] in Serum
346
1203
1.46
9.17
1.1
1.1
u/ml
2.3
2.0
0.10
109
327
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
184
552
1.69
9.17
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1066
6596
0.81
9.16
1.5
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
128
345
1.88
9.06
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
233
747
1.58
8.98
3.9
2.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
46
78
2.99
8.86
1.2
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
57
110
2.62
8.80
1.1
1.2
umol/24h
1.9
1.7
0.41
57
110
(3027035) Albumin [Mass/time] in 24 hour Urine
57
110
2.62
8.80
1.2
1.3
mg/24h
639.3
219.1
—
9
21
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
114
300
1.93
8.67
1.1
1.2
%
80.6
90.3
1.07
35
83
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
29
4.54
8.62
1.0
1.0
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
40
64
3.16
8.45
1.0
1.1
u/ml
21.2
20.9
—
8
9
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
40
64
3.16
8.45
1.0
1.1
u/ml
23.7
15.6
—
10
9
(3013247) Albumin in CSF/Albumin in Serum or Plasma
123
336
1.85
8.40
1.0
1.1
mg/g
6.9
6.1
0.55
115
323
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
211
672
1.59
8.40
2.1
2.2
ug/min
112.2
124.4
0.08
48
136
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
101
258
1.98
8.36
1.2
1.2
pmol/l
248.5
331.4
1.50
71
198
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
428
1574
1.38
8.36
1.6
1.5
%
29.7
31.7
0.53
273
971
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
562
2156
1.32
8.35
2.2
2.2
pg
32.7
32.7
0.06
556
2139
(3002621) Streptococcal DNAse B [Units/volume] in Serum
60
123
2.47
8.28
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
461
1719
1.36
8.27
2.1
1.8
ug/l
21.3
27.4
2.08
453
1698
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
41
68
3.05
8.21
1.3
1.4
%
34.2
35.6
0.06
28
58
(3011335) Digoxin [Mass/volume] in Serum or Plasma
43
74
2.94
8.12
2.2
2.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
65
140
2.35
8.11
1.4
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
250
837
1.51
8.03
1.8
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
56
113
2.51
7.98
1.2
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
63
135
2.36
7.95
1.1
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
62
132
2.38
7.94
1.1
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
34
51
3.38
7.90
7.2
12.4
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
38
62
3.10
7.82
1.3
1.4
%
12.0
14.2
0.20
27
55
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
944
3896
1.23
7.81
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
602
2356
1.30
7.78
1.5
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
71
163
2.21
7.71
3.4
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
159
482
1.67
7.71
3.6
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
159
482
1.67
7.71
3.6
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
195
623
1.59
7.71
1.6
1.9
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
114
314
1.84
7.64
1.3
1.3
%
107.2
107.6
0.04
109
292
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
46
86
2.71
7.58
1.2
1.1
nmol/l
15.4
13.3
0.34
15
24
(3014599) Egg white IgE Ab [Units/volume] in Serum
334
1199
1.41
7.56
1.1
1.1
u/ml
2.6
4.1
0.25
99
283
(3012898) Urea [Moles/volume] in Urine
60
129
2.36
7.54
1.2
1.5
mmol/l
169.4
172.5
0.05
55
109
(3013166) Neutrophils/100 leukocytes in Synovial fluid
149
447
1.69
7.52
1.4
1.3
%
49.8
56.4
1.15
119
385
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
125
357
1.77
7.48
1.0
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
264
909
1.47
7.45
2.9
2.4
ph
7.4
7.4
0.02
69
374
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
28
38
3.73
7.44
1.0
1.0
u/ml
0.2
0.5
0.23
15
15
(3028308) Erythrocytes [#/volume] in Pleural fluid
418
1564
1.36
7.40
1.6
1.4
e6/l
84420.2
49684.6
0.94
266
862
(3043410) Blood group antigens tested for on Red Blood Cells
134
393
1.73
7.34
1.6
1.7
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
37
62
3.02
7.32
5.7
4.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
389
1442
1.37
7.31
1.4
1.3
mmol/l
6.3
6.1
0.96
358
1332
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
81
201
2.04
7.30
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
67
154
2.20
7.28
1.3
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
66
153
2.18
7.05
1.2
1.1
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
32
50
3.24
7.05
1.1
1.1
umol/24h
0.5
0.4
0.16
14
20
(3036048) Francisella tularensis Ab [Titer] in Serum
123
357
1.75
7.00
1.2
1.2
titre
845.7
160.0
—
7
23
(40763590) HLA-DQ beta [Type]
26
35
3.76
6.99
1.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
58
129
2.28
6.82
1.1
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
77
193
2.02
6.80
1.1
1.1
pmol/l
8.2
12.1
—
10
26
(3013862) HLA-DP [Type]
26
36
3.66
6.76
1.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
52
111
2.37
6.68
1.3
1.1
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
39
72
2.74
6.61
1.1
1.0
u/ml
1.1
0.2
0.49
15
32
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
21
25
4.25
6.53
8.3
10.6
%
50.3
43.3
—
7
16
(40760410) HLA-B [Type] by High resolution
26
37
3.56
6.53
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
26
37
3.56
6.53
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
26
37
3.56
6.53
1.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
50
106
2.39
6.53
4.4
4.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
23
30
3.88
6.45
9.5
9.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
27
40
3.42
6.43
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
57
130
2.22
6.36
9.0
6.8
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
40
77
2.63
6.31
1.1
1.1
u/ml
1.2
3.9
1.04
27
52
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
115
339
1.72
6.26
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
962
4075
1.20
6.22
2.7
2.3
%
16.7
16.6
0.24
554
1928
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
64
155
2.09
6.20
1.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
39
75
2.63
6.17
1.2
1.0
u/l
75.1
50.9
0.32
33
60
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
63
152
2.10
6.17
1.4
1.4
%
69.4
69.7
0.02
54
124
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
55
126
2.21
6.09
1.1
1.1
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
46
98
2.38
5.98
1.0
1.1
u/ml
0.4
1.1
1.26
26
65
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
69
175
2.00
5.96
11.8
7.1
umol/l
0.4
0.3
0.91
64
156
(3006442) Creatine [Moles/volume] in Serum or Plasma
325
1213
1.36
5.95
1.5
1.4
umol/l
66.0
72.4
0.90
16
108
(3036180) Methadone [Presence] in Urine
14
12
5.91
5.94
2.1
1.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
48
105
2.31
5.90
1.3
1.4
pmol/l
11.8
20.9
0.93
40
94
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
36
68
2.68
5.90
3.8
3.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
105
308
1.73
5.85
1.2
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
428
1670
1.30
5.80
1.6
1.6
mmol/l
7.8
7.5
2.19
245
939
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
23
33
3.53
5.74
1.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
75
199
1.91
5.73
1.7
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
135
427
1.60
5.69
2.4
1.5
e6/l
9941.7
10228.6
0.02
75
201
(3036603) Volume of Urine
272
999
1.38
5.54
1.9
1.6
ml
2196.8
1959.5
1.07
87
191
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
103
306
1.70
5.52
1.1
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
51
119
2.17
5.46
2.7
2.0
mg/l
3.3
3.1
0.21
51
113
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
101
300
1.71
5.42
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
103
308
1.69
5.40
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
103
308
1.69
5.40
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
72
194
1.88
5.30
1.6
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
518
2097
1.25
5.27
21.8
6.0
mmol/l
7.9
7.1
3.40
434
1729
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
95
280
1.72
5.25
1.3
1.2
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
14
14
5.06
5.21
1.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
12
10
6.07
5.21
1.0
1.0
—
—
—
0
0
(3025315) Body weight
51
122
2.12
5.16
4.6
3.9
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
155
519
1.51
5.16
1.1
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
67
178
1.91
5.15
2.7
2.4
pmol/l
49.5
70.4
0.80
58
158
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
90
263
1.73
5.13
1.3
1.8
ug/l
1.9
4.4
0.83
42
173
(40762887) Creatinine [Moles/volume] in Blood
17
21
4.10
5.11
1.2
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
29
53
2.77
5.07
1.3
1.3
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
30
56
2.71
5.06
1.1
1.3
%
0.5
1.0
1.03
19
49
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
98
295
1.68
5.05
2.8
2.3
mg/l
58.6
35.0
0.40
19
35
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
40
87
2.33
5.03
1.1
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
354
1375
1.31
5.03
1.6
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
153
1133
0.68
5.00
1.3
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
51
124
2.08
4.98
3.6
2.1
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
36
75
2.43
4.96
3.1
2.7
pmol/l
10.3
54.0
0.50
12
29
(3035880) pH of Pleural fluid
221
802
1.40
4.89
1.4
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
12
8
7.59
4.86
1.7
1.5
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
62
164
1.91
4.85
3.2
2.8
umol/l
38.8
45.8
1.16
46
144
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
25
43
2.94
4.84
1.3
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
39
86
2.30
4.78
1.1
1.1
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
29
55
2.67
4.77
1.1
1.1
mg/l
0.0
0.8
0.51
22
49
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
45
106
2.15
4.76
1.3
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
16
20
4.05
4.75
6.3
3.4
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
126
412
1.55
4.71
1.4
1.2
mmol/l
3.3
3.7
0.64
114
380
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
22
36
3.09
4.61
6.9
5.4
mg/l
0.9
1.7
1.08
17
31
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
99
307
1.63
4.60
1.2
1.1
mg/l
66.6
34.5
0.27
76
225
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
35
75
2.36
4.57
1.3
1.1
—
610.0
—
0
5
(3020618) Glucose [Moles/volume] in Synovial fluid
23
39
2.99
4.57
1.0
1.1
mmol/l
6.3
4.9
1.07
16
29
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
24
42
2.89
4.54
11.8
8.3
—
—
—
0
0
(4133840)
140
473
1.50
4.53
1.2
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
125
412
1.54
4.53
1.0
1.1
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
44
105
2.12
4.53
3.1
2.1
%
11.0
14.7
0.31
11
29
(3026470) Cobalt [Mass/volume] in Blood
225
831
1.37
4.52
1.9
2.0
ug/l
3.4
3.6
0.10
201
741
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
89
270
1.67
4.50
3.0
5.0
u/l
89.3
53.7
0.32
25
108
(3013336) Amino acids [Identifier] in Serum or Plasma
18
26
3.50
4.50
3.6
2.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
59
158
1.89
4.48
1.3
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
51
130
1.99
4.45
1.3
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
2188
12161
0.91
4.44
1.5
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
125
414
1.53
4.44
2.6
1.7
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
107
342
1.58
4.43
1.5
1.2
g/l
13.8
13.4
0.14
79
257
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
440
1789
1.25
4.40
1.4
1.4
mmol/l
12.1
11.7
0.31
129
291
(3025549) Creatine [Moles/time] in 24 hour Urine
40
93
2.18
4.39
1.5
1.4
—
14.3
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
760
3263
1.18
4.37
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
153
531
1.46
4.36
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
759
3264
1.18
4.29
1.1
1.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
16
22
3.68
4.26
2.3
2.5
mu/l
3.4
1.6
0.61
16
22
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
63
176
1.81
4.24
1.7
1.7
mg/l
1.5
1.8
0.94
57
144
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
35
78
2.27
4.23
2.3
1.4
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
19
30
3.21
4.21
1.5
1.9
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
92
288
1.62
4.17
1.6
1.3
g/l
24.7
47.2
0.60
69
231
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1539
6971
1.12
4.16
1.7
1.6
mg/l
4.4
3.3
2.35
1120
4624
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
48
123
1.98
4.15
1.2
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
219
819
1.35
4.12
2.0
2.1
ug/l
2.2
2.3
0.08
181
711
(3012441) Differential panel - Pleural fluid
386
1560
1.25
4.10
1.6
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
155
548
1.43
4.05
1.5
1.4
%
64.2
62.9
0.16
121
462
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
7
7.23
4.03
1.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
20
34
2.98
3.99
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
166
598
1.41
3.92
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
35
81
2.19
3.91
1.3
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
73
219
1.69
3.90
1.0
1.0
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
39
95
2.08
3.87
1.1
1.6
u/ml
7.5
9.1
0.06
32
76
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
161
579
1.41
3.85
1.2
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
27
56
2.44
3.82
1.0
1.1
mmol/l
8.1
8.8
1.13
27
56
(3049233) Organic acids panel - Urine
11
12
4.64
3.78
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
123
422
1.48
3.77
1.4
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
78
241
1.64
3.76
2.7
2.9
u/l
3186.0
1622.7
0.40
72
221
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
85
269
1.60
3.73
5.0
4.8
ug/min
38.4
50.5
1.06
60
220
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
74
226
1.66
3.73
1.0
1.0
ug/l
77.9
78.8
0.06
64
191
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
52
143
1.84
3.72
4.5
2.5
mg/l
1.4
1.3
0.09
37
94
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
19
33
2.91
3.68
1.2
1.5
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
33
77
2.17
3.64
1.5
1.3
pmol/l
13.5
16.4
0.53
26
69
(3050794) Legionella sp Ab [Presence] in Serum
47
126
1.89
3.63
1.1
1.1
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
16
25
3.24
3.62
1.1
1.0
u/ml
3.0
12.4
1.54
11
18
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
513
3092
0.84
3.62
1.2
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
27
58
2.36
3.57
1.2
1.6
nmol/l
33.8
17.4
0.65
27
58
(3041918) Cholesterol [Moles/volume] in Pleural fluid
81
257
1.60
3.54
1.2
1.2
mmol/l
1.6
1.6
0.13
54
148
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
24
49
2.48
3.52
1.1
1.1
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
10
9
5.62
3.49
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
383
1579
1.23
3.47
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
270
1727
0.79
3.45
1.5
1.5
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
16
26
3.11
3.44
1.1
1.0
u/ml
0.9
0.8
0.02
11
20
(3042010) Triglyceride [Moles/volume] in Pleural fluid
63
189
1.69
3.42
1.3
1.2
mmol/l
1.1
1.5
0.25
45
113
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
297
1193
1.26
3.40
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
1140
5141
1.13
3.40
4.5
3.6
ph
7.4
7.4
0.54
963
4496
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
24
50
2.43
3.39
1.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
38
97
1.98
3.38
1.4
1.2
umol/24h
300.4
316.3
0.28
38
97
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
27
60
2.28
3.35
1.6
1.5
u/l
0.0
0.3
—
7
18
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
39
101
1.95
3.34
1.1
1.1
u/l
6.4
12.2
1.28
39
101
(3041806) Other cells [#/volume] in Blood by Manual count
150
1032
0.73
3.33
1.6
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
31
74
2.12
3.27
1.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
33
81
2.06
3.26
1.3
1.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
66
204
1.64
3.23
1.5
1.5
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
63
194
1.64
3.14
2.2
2.4
ug/l
4.8
4.7
0.02
28
50
(3013762) Body weight Measured
23
49
2.38
3.13
1.2
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
10
12
4.22
3.13
3.0
2.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
237
938
1.28
3.10
2.5
2.5
u/l
201.2
205.3
0.35
237
931
(3017958) Strawberry IgE Ab [Units/volume] in Serum
18
34
2.68
3.07
1.1
1.0
u/ml
0.2
0.1
—
10
20
(3017461) Flecainide [Moles/volume] in Serum or Plasma
28
67
2.12
2.97
1.7
1.4
umol/l
0.7
0.7
0.16
22
50
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
15
26
2.92
2.94
1.0
1.1
%
2.6
2.4
0.13
15
26
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
33
85
1.97
2.91
1.1
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
276
1123
1.25
2.90
1.1
1.0
u/ml
1.1
0.5
0.74
59
140
(3033799) Differential panel - Peritoneal fluid
121
439
1.40
2.86
2.3
1.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
48
141
1.72
2.86
2.1
2.9
u/field
0.6
0.5
0.19
48
141
(3025296) Carrot IgE Ab [Units/volume] in Serum
14
24
2.95
2.80
1.0
1.0
u/ml
4.5
0.1
—
7
10
(3027696) Helicobacter pylori Ab [Titer] in Serum
9
10
4.55
2.77
1.1
1.0
titre
1082.2
1547.0
—
9
10
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
29
73
2.01
2.73
1.1
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
102
363
1.42
2.71
1.3
1.2
ug/l
620.7
185.3
0.68
55
185
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
28
70
2.02
2.69
1.2
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
52
160
1.65
2.65
1.7
1.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
101
707
0.72
2.60
7.1
6.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
101
707
0.72
2.60
3.5
3.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
681
3037
1.14
2.54
3.1
2.2
%
13.2
13.1
0.76
673
2991
(3017937) Magnesium [Moles/time] in 24 hour Urine
20
45
2.25
2.47
1.2
1.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
48
148
1.64
2.45
1.3
1.1
u/l
19.8
19.6
0.01
27
100
(3000285) Sodium [Moles/volume] in Blood
54
172
1.59
2.44
1.1
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
103
376
1.39
2.41
2.2
2.2
ng/l
105.4
95.9
0.27
61
176
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
18
39
2.34
2.41
1.2
1.0
pmol/l
272.8
222.1
0.19
12
21
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
294
1234
1.21
2.37
2.7
1.7
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
24
60
2.02
2.34
6.5
3.8
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
16
34
2.38
2.24
1.0
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
19
44
2.19
2.23
1.1
1.1
nmol/l
227.2
265.3
0.31
19
44
(3025886) Oxalate [Mass/time] in 24 hour Urine
19
44
2.19
2.23
1.1
1.4
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
7
8
4.43
2.20
1.0
1.0
nmol/l
269.1
271.4
—
7
8
(40765089) Chromosome analysis panel - Blood by G-banded
172
688
1.27
2.19
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1151
6350
0.92
2.18
1.6
1.6
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
20
48
2.11
2.17
1.4
1.3
nmol/l
426.4
530.1
0.35
20
48
(3034891) Synovial lining cells/100 cells in Synovial fluid
206
843
1.24
2.16
1.6
1.4
%
5.5
4.1
0.36
51
215
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
140
547
1.30
2.15
2.2
2.3
nmol/l
169.6
149.0
0.77
122
445
(3016273) Islet cell 512 Ab [Units/volume] in Serum
46
146
1.59
2.14
1.1
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
278
1174
1.20
2.14
1.1
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
26
70
1.88
2.10
1.1
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
559
2498
1.13
2.09
2.0
1.7
%
90.3
89.7
1.87
549
2458
(3027315) Oxygen [Partial pressure] in Blood
997
4603
1.10
2.07
4.4
3.7
kpa
8.8
8.7
2.44
968
4503
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
7
9
3.94
2.02
3.0
3.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
293
1253
1.18
1.99
3.0
2.1
—
—
—
0
0
(3004451) EKG impression Narrative
202
835
1.23
1.96
1.3
1.2
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
51
170
1.52
1.96
1.7
1.6
ug/l
106.7
111.9
0.13
43
138
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
3971
19256
1.05
1.95
3.6
3.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
14
30
2.36
1.95
1.2
1.2
mmol/24h
2.5
2.1
0.32
14
30
(3013290) Carbon dioxide [Partial pressure] in Blood
991
4591
1.09
1.94
4.4
3.6
kpa
5.0
5.0
0.20
963
4491
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
29
84
1.75
1.90
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
990
4591
1.09
1.90
4.4
3.6
mmol/l
2.3
2.5
1.76
656
3087
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
10
18
2.81
1.89
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
10
18
2.81
1.89
2.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
10
18
2.81
1.89
2.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
10
18
2.81
1.89
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
10
18
2.81
1.89
1.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
10
18
2.81
1.89
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
101
668
0.76
1.87
1.3
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
48
160
1.52
1.86
1.4
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
681
3107
1.11
1.84
2.1
1.7
mmol/l
1.7
1.8
1.04
666
3034
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
41
133
1.56
1.80
1.1
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
31
94
1.67
1.76
1.2
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
40
130
1.56
1.75
1.1
1.0
—
—
—
0
0
(4212803)
40
130
1.56
1.75
1.1
1.0
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
6
8
3.80
1.74
1.0
1.0
u/ml
11.1
2.4
—
6
8
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
138
556
1.26
1.73
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
66
239
1.40
1.72
1.3
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
229
974
1.19
1.71
1.6
1.6
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
8
14
2.89
1.70
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
815
4503
0.91
1.68
3.8
3.0
mg/l
28.3
27.5
0.23
513
2962
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1311
6192
1.07
1.65
1.4
1.4
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
38
124
1.55
1.65
1.2
1.2
mg/l
56.4
46.6
—
9
38
(3029612) Listeria sp Ab [Titer] in Serum
10
20
2.53
1.60
1.4
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
93
361
1.30
1.58
1.2
1.2
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
6
9
3.37
1.58
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
235
1019
1.17
1.45
1.2
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
25
76
1.66
1.45
1.2
1.4
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
16
42
1.93
1.44
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
225
975
1.17
1.41
2.0
2.3
ml
1949.1
2005.3
0.32
197
887
(4281824)
323
1852
0.88
1.40
1.2
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
39
283
0.70
1.39
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
917
4993
0.93
1.39
1.5
1.5
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
13
32
2.06
1.38
1.0
1.0
u/ml
0.2
0.1
—
5
15
(3032641) Amino acids panel - Urine
8
15
2.70
1.38
1.3
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
27
86
1.59
1.33
1.9
1.5
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
6
11
2.76
1.32
1.0
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
15
40
1.90
1.31
1.3
1.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
38
132
1.46
1.29
1.3
1.1
mg/l
8.4
8.9
0.12
31
124
(3034614) HLA Ag [Interpretation]
11
26
2.14
1.29
1.1
1.1
—
—
—
0
0
(40758358) Immune stain study
17
48
1.79
1.27
1.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
385
1746
1.12
1.27
1.4
1.3
pmol/l
69.1
138.2
0.71
127
491
(3035933) Granulocytes/100 leukocytes in Blood
136
571
1.21
1.25
2.1
1.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
62
237
1.32
1.24
2.9
3.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
67
260
1.30
1.21
1.4
1.2
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
8
18
2.25
1.21
1.5
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
14
38
1.86
1.18
2.1
2.4
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
12
31
1.96
1.15
1.6
1.3
nmol/l
153.3
122.9
—
7
20
(44806420)
78
495
0.80
1.15
2.1
2.3
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
10
24
2.11
1.14
2.6
2.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
18
54
1.69
1.13
1.1
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
30
103
1.47
1.11
1.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
9
22
2.07
1.07
1.2
1.4
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
33
117
1.43
1.05
1.2
1.2
ug/l
106.6
111.4
0.08
17
76
(1617658) Protocol used for examination of sentinel lymph nodes
211
1215
0.88
1.05
1.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
9
23
1.98
1.04
1.2
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
15
44
1.73
1.02
1.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
242
1377
0.89
1.01
1.3
1.3
g/l
1.5
1.5
0.09
22
31
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
18
141
0.65
1.01
1.3
2.0
%
9.2
19.7
—
10
62
(3032743) Legionella sp IgG Ab [Presence] in Serum
31
110
1.43
1.00
1.1
1.1
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
9
24
1.90
0.99
1.0
1.2
nmol/24h
81.9
87.7
—
9
24
(3028468) Fragments [Presence] in Blood by Light microscopy
6
12
2.53
0.99
3.5
2.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
728
3934
0.94
0.98
1.6
1.6
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
13
37
1.78
0.98
1.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
22
73
1.53
0.97
1.0
1.0
%
8.8
8.8
0.03
22
64
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
22
73
1.53
0.97
1.1
1.0
%
35.1
36.1
0.42
22
65
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
22
73
1.53
0.97
1.1
1.0
%
20.4
21.7
1.00
22
64
(21494567) Legionella sp IgM Ab [Presence] in Serum
32
115
1.41
0.97
1.1
1.1
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
6
13
2.34
0.95
1.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
105
446
1.19
0.93
1.6
1.4
%
22.8
22.1
0.09
95
406
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
13
38
1.73
0.91
1.1
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
52
205
1.28
0.90
1.1
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
28
100
1.42
0.89
1.1
1.1
s
36.0
37.9
0.80
22
85
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
59
237
1.26
0.89
1.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
324
1492
1.10
0.88
1.6
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
26
92
1.43
0.87
1.9
1.4
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
28
101
1.40
0.85
1.2
1.3
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
6
15
2.02
0.85
1.3
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
22
77
1.45
0.79
1.7
1.8
mpas
1.6
1.9
1.22
12
40
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
5
11
2.30
0.78
1.2
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
31
117
1.34
0.75
1.1
1.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
22
154
0.72
0.74
1.0
1.0
kpa
4.2
3.6
0.78
17
131
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
623
2975
1.06
0.71
1.3
1.3
ug/l
3.4
4.0
0.62
556
2706
(3001019) Free T4 and TSH panel - Serum or Plasma
2105
10964
0.97
0.66
1.6
1.6
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
8
23
1.76
0.66
1.0
1.1
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
8
23
1.76
0.66
1.3
1.1
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
12
0.00
0.63
0.0
1.1
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
12
0.00
0.63
0.0
1.1
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
12
0.00
0.63
0.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
25
95
1.33
0.61
1.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
78
0.65
0.61
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
283
1326
1.08
0.60
1.2
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
36
145
1.26
0.59
1.5
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1076
5650
0.96
0.57
1.8
1.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
24
158
0.77
0.57
1.0
1.0
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
38
155
1.24
0.56
1.3
1.6
umol/l
0.2
0.2
—
10
65
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
58
248
1.18
0.55
1.6
1.4
%
8.9
10.4
0.19
27
142
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
24
157
0.77
0.55
1.0
1.0
kpa
6.4
7.3
1.24
19
135
(40768795) Lymph node Pathology biopsy report
373
1775
1.06
0.53
1.2
1.2
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
13
45
1.46
0.52
1.0
1.1
g/l
0.0
0.4
—
6
11
(3011325) HIV 1+2 Ab [Presence] in Serum
27
107
1.28
0.51
1.1
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
70
307
1.15
0.51
1.0
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
10
74
0.68
0.49
1.2
1.2
ng/l
3511.8
2377.6
—
5
58
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
8
62
0.65
0.48
1.0
1.0
g/l
171.3
166.1
—
8
62
(46235168) Fasting glucose [Moles/volume] in Blood
56
243
1.17
0.47
2.2
2.1
mmol/l
7.5
7.0
0.46
22
87
(44786800) Granulocytes/100 leukocytes in Body fluid
45
193
1.18
0.44
1.3
1.4
%
26.1
23.7
0.17
38
146
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
13
47
1.40
0.44
1.3
1.0
mmol/l
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
8
28
1.45
0.44
1.0
1.2
—
—
—
0
0
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
8
0.00
0.43
0.0
1.3
—
1.4
—
0
8
(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.43
0.0
1.1
—
5.5
—
0
8
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
8
29
1.40
0.42
1.0
1.0
—
—
—
0
0
(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum
0
10
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum
0
10
0.00
0.41
0.0
1.1
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
9
33
1.38
0.39
1.2
1.2
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
26
160
0.82
0.39
1.5
2.1
%
56.9
56.6
0.01
15
97
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
77
349
1.12
0.38
1.8
2.7
mmol/l
7.7
7.2
0.44
49
176
(3050129) First trimester maternal screen panel - Serum or Plasma
1516
7500
1.02
0.37
1.5
1.4
—
—
—
0
0
(3022670) pH of Venous cord blood
13
49
1.34
0.36
1.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
59
336
0.89
0.36
5.5
5.9
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
6
22
1.38
0.35
1.3
1.3
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
6
22
1.38
0.35
1.0
1.0
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
22
1.38
0.35
1.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
14
54
1.31
0.34
1.1
1.2
—
—
—
0
0
(4038314)
40
175
1.16
0.34
1.3
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
501
2444
1.04
0.33
1.3
1.2
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
7
25
1.42
0.33
1.0
1.0
mmol/24h
121.9
158.2
—
7
25
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
94
436
1.09
0.32
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
152
720
1.07
0.31
1.1
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
22
92
1.21
0.30
1.1
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
243
1171
1.05
0.29
1.6
1.4
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
18
74
1.23
0.29
1.2
1.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
8
31
1.31
0.29
1.0
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
5
37
0.68
0.27
6.2
5.8
mmol/l
0.1
0.2
—
5
37
(3003157) Bacteria [#/volume] in Mother's milk
9
37
1.23
0.26
10.1
6.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
13
52
1.27
0.26
1.2
1.1
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
5
18
1.41
0.24
1.6
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
45
205
1.11
0.24
2.8
2.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
683
3539
0.98
0.23
1.3
1.3
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
228
1203
0.96
0.23
1.4
1.4
nmol/l
31.5
33.0
0.28
204
1126
(40762365) Oxygen content in Arterial blood by calculation
74
347
1.08
0.22
2.4
3.0
ml/dl
14.9
14.8
0.14
67
330
(40768800) Prostate Pathology biopsy report
660
3418
0.98
0.22
1.2
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
109
521
1.06
0.20
1.5
1.4
%
4.5
2.5
1.03
90
444
(3006567) Chloride [Moles/time] in 24 hour Urine
6
25
1.21
0.20
1.3
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
19
83
1.16
0.18
2.4
3.8
—
0.0
—
0
11
(3029396) Erythrocyte agglutination [Presence] in Blood
118
624
0.96
0.16
2.9
3.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
21
119
0.89
0.15
1.0
1.1
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
21
119
0.89
0.15
1.5
1.1
u/field
0.9
1.2
1.18
14
76
(3035611) Eosinophils/100 leukocytes in Synovial fluid
28
129
1.10
0.14
1.6
1.7
%
1.0
0.6
0.30
18
101
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
217
1071
1.03
0.12
1.6
1.5
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
5
22
1.15
0.10
1.2
1.0
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
5
23
1.10
0.10
1.0
1.0
%
41.7
33.2
—
5
23
(3020093) Fractional oxyhemoglobin in Venous cord blood
6
29
1.05
0.08
1.0
1.0
%
64.8
65.8
—
6
29
(36303858) Crystals [Presence] in Urine
6
29
1.05
0.08
1.2
1.1
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
5
33
0.77
0.08
1.0
1.1
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
14
78
0.91
0.07
1.0
1.1
u/field
1.3
1.0
—
8
48
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
15
69
1.10
0.07
1.2
1.5
u/field
1.1
1.1
—
8
41
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
26
140
0.94
0.07
1.0
1.1
iu/ml
18.1
15.8
—
7
57
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
17
80
1.08
0.05
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
22
105
1.06
0.05
1.1
1.5
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
33
174
0.96
0.04
1.1
1.1
g/l
16.7
17.7
0.28
26
156
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
23
122
0.95
0.03
1.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
23
111
1.05
0.03
1.0
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
45
234
0.97
0.03
1.2
1.2
mmol/l
20.9
20.5
0.24
34
193
(3025130) Human papilloma virus identified in Specimen
497
2526
1.00
0.02
1.7
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
467
2358
1.00
0.01
3.3
3.3
u/ml
26.8
40.8
1.55
450
2268
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
211
1071
1.00
0.00
1.6
1.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
28
139
1.02
0.00
1.0
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
32
163
0.99
0.00
1.0
1.0
mu/l
9.7
8.8
0.35
26
130
(3027540) Rickettsia typhi Ab [Titer] in Serum
5
27
0.94
0.00
1.0
1.1
—
—
—
0
0
(3035963) Corticotropin [Moles/volume] in Plasma
0
5
0.00
0.00
0.0
1.0
—
12.5
—
0
5
(3021691) Plasmodium malariae Ab [Titer] in Serum
5
26
0.97
0.00
2.4
2.3
—
—
—
0
0
(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG
0
5
0.00
0.00
0.0
2.8
—
3.4
—
0
5
(3003195) risperiDONE [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
7
35
1.01
0.00
1.1
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_OTHER_SPECIAL_EXAM_INVES_PERSONS_WO_COMPLA_REPOR_DIAGNOSIS – Other special examinations and investigations of persons without complaint or reported diagnosis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).